1096 lines
98 KiB
Markdown
1096 lines
98 KiB
Markdown
# Practical Longevity Guidelines
|
||
|
||
**What this document is:** Actionable guidance for extending healthspan and lifespan, grounded in the bioenergetic framework described in METABOLISM_AND_AGING.md and the research plan in PLAN.md. This covers practical topics — environmental toxins, water quality, supplementation rationale, lifestyle strategies — that don't fit neatly into the more focused documents.
|
||
|
||
**Guiding principle:** Aging is primarily a decline in cellular energy production. Interventions that protect and restore mitochondrial function, support thyroid-driven metabolic rate, and remove chronic low-grade toxin exposure are the highest-leverage actions available today.
|
||
|
||
---
|
||
|
||
## Table of Contents
|
||
|
||
1. [Environmental Toxin Avoidance](#1-environmental-toxin-avoidance)
|
||
2. [Water Quality](#2-water-quality)
|
||
3. [Food Preparation and Anti-Nutrients](#3-food-preparation-and-anti-nutrients)
|
||
4. [The Seed Oil Elimination Timeline](#4-the-seed-oil-elimination-timeline)
|
||
5. [Sugar, Glucose, and Metabolic Rate](#5-sugar-glucose-and-metabolic-rate)
|
||
6. [Cholesterol and Saturated Fat — Essential, Not Harmful](#6-cholesterol-and-saturated-fat--essential-not-harmful)
|
||
7. [Supplementation Rationale](#7-supplementation-rationale)
|
||
8. [The Antioxidant Paradox](#8-the-antioxidant-paradox)
|
||
9. [Metabolic Assessment — Body Temperature and Self-Monitoring](#9-metabolic-assessment--body-temperature-and-self-monitoring)
|
||
10. [CO2, Breathing, and Oxygen Delivery](#10-co2-breathing-and-oxygen-delivery)
|
||
11. [Sleep and Circadian Rhythm](#11-sleep-and-circadian-rhythm)
|
||
12. [Sunlight and Light Exposure](#12-sunlight-and-light-exposure)
|
||
13. [Exercise for Longevity](#13-exercise-for-longevity)
|
||
14. [Sauna and Heat Exposure](#14-sauna-and-heat-exposure)
|
||
15. [Cold Exposure — Hormesis, Not Chronic](#15-cold-exposure--hormesis-not-chronic)
|
||
16. [Gut Health and the Microbiome](#16-gut-health-and-the-microbiome)
|
||
17. [Stress and Hormonal Balance](#17-stress-and-hormonal-balance)
|
||
18. [Conventional Wisdom Under Scrutiny](#18-conventional-wisdom-under-scrutiny)
|
||
|
||
---
|
||
|
||
## 1. Environmental Toxin Avoidance
|
||
|
||
The modern environment contains several chronic, low-dose toxins that directly impair the metabolic machinery this framework aims to protect. Unlike acute poisons, these accumulate over years and produce gradual metabolic decline that looks indistinguishable from "normal aging." Removing them doesn't produce overnight results — it removes a persistent drag on the system.
|
||
|
||
### 1.1 Fluoride
|
||
|
||
**Why it matters:** Fluoride is a direct thyroid toxin, a mitochondrial enzyme inhibitor, and a pineal gland calcifier. It was historically used as anti-thyroid medication at 2-10 mg/day — a dose range that overlaps with the total daily intake of people in fluoridated areas who drink tea (estimated 1.6-6.3 mg/day). See METABOLISM_AND_AGING.md Section 6.5 for the full biochemistry.
|
||
|
||
**Mechanisms of harm:**
|
||
- Competes with iodine at the thyroid's sodium-iodide symporter (NIS) → reduced T4/T3 synthesis
|
||
- Inhibits selenoenzyme deiodinases (D1, D2) → impaired T4→T3 conversion
|
||
- Inhibits enolase (glycolysis), ATP synthase (Complex V), cytochrome c oxidase (Complex IV), succinate dehydrogenase (Complex II), and aconitase (TCA cycle) → comprehensive blockade of cellular energy production
|
||
- Calcifies the pineal gland → reduced melatonin production → impaired sleep and loss of a key mitochondrial antioxidant
|
||
- Neurotoxic — NTP 2024 review found moderate-confidence evidence of IQ reduction at ≥1.5 mg/L water fluoride; 2024 US Federal Court ruled 0.7 mg/L poses unreasonable risk
|
||
- Bone half-life of 8-20 years → progressive lifetime accumulation
|
||
|
||
**Sources of exposure:**
|
||
|
||
| Source | Fluoride Content | Notes |
|
||
|--------|-----------------|-------|
|
||
| Fluoridated tap water | 0.7 mg/L (US/AU standard) | ~1 mg per 1.5L consumed |
|
||
| Black/green tea (brewed) | 1-6 mg/L | Tea plants hyperaccumulate fluoride from soil; tea bags ~2x loose leaf |
|
||
| Toothpaste (swallowed) | 1000-1500 ppm | Children swallow 30-75% of paste used |
|
||
| Processed food/beverages | Variable | Anything manufactured with fluoridated water |
|
||
| Mechanically deboned meat | Elevated | Bone fragments contribute fluoride |
|
||
| Pesticide residues (cryolite, sulfuryl fluoride) | Variable | Used on grapes, grains, dried foods |
|
||
| Fluorinated pharmaceuticals | Variable | ~20-25% of drugs contain fluorine atoms (SSRIs, fluoroquinolones, statins) |
|
||
|
||
**Reducing intake (the most important step):**
|
||
- **Filter drinking and cooking water** — distillation (~99%+ removal), reverse osmosis (~90-95%), or activated alumina (~90%). Standard carbon/Brita filters do not remove fluoride.
|
||
- **Reduce tea intake or switch types** — black/green tea bags are the highest fluoride source. White tea (young leaves, ~10x less fluoride), herbal teas (not *Camellia sinensis*), and coffee (negligible fluoride) are alternatives. If keeping tea, use loose-leaf (roughly half the fluoride of bags) and drink it with milk (calcium reduces absorption — see below).
|
||
- **Use fluoride-free toothpaste** — hydroxyapatite toothpaste is an effective remineralisation alternative.
|
||
- **Cook with filtered water** — fluoride in cooking water transfers to food.
|
||
|
||
**Reducing absorption of fluoride you do ingest:**
|
||
- **Co-ingest calcium** — calcium forms insoluble CaF₂ in the gut, reducing fluoride absorption by 20-50% (Ekstrand & Ehrnebo, 1979). Drinking tea with milk, or consuming fluoride-containing water/food alongside dairy or calcium-rich foods, meaningfully reduces uptake. Fluoride absorbed on an empty stomach has ~80-90% bioavailability; with calcium-rich food this drops to ~50-70%.
|
||
- **Co-ingest magnesium** — MgF₂ is also insoluble. Similar mechanism to calcium, less studied in humans but sound chemistry.
|
||
- **Avoid drinking fluoridated water on an empty stomach** — absorption is highest when there's nothing else in the gut to bind the fluoride.
|
||
|
||
**Enhancing excretion of absorbed fluoride:**
|
||
- **Alkalinise urine** — fluoride is reabsorbed in renal tubules via non-ionic diffusion of HF (hydrogen fluoride). In acidic urine, more F⁻ is protonated to HF (pKa 3.17), which is uncharged and crosses tubular membranes back into the blood. In alkaline urine, F⁻ stays ionised and cannot cross membranes, so it is excreted. Alkaline urine increases fluoride clearance by 30-50% (Whitford, 1996).
|
||
|
||
*Mechanistic note — how urine pH changes without affecting blood pH:* Blood pH is tightly regulated at 7.35-7.45, and the kidneys are the primary mechanism for maintaining it. They do this by adjusting how much acid or bicarbonate they excrete in urine — urine is the exhaust. Urine pH ranges from 4.5 to 8.0 depending on what the kidneys need to dump. When you eat fruit and vegetables, the organic acid salts they contain (citrate, malate, etc.) are metabolised in the liver to bicarbonate (HCO₃⁻). This bicarbonate load is handled by the kidneys excreting the excess in urine, making it alkaline — while blood pH remains unchanged. Conversely, high-protein and grain-heavy diets generate sulfuric acid from sulfur-containing amino acids, which the kidneys excrete as acid, making urine more acidic. The blood stays the same either way; only the urine shifts.
|
||
|
||
*Practical approaches to alkaline urine:*
|
||
- **Fruit- and vegetable-rich diet** — the most natural approach. Citrus fruits, bananas, potatoes, and leafy greens are all net base-producing. This aligns with the broader metabolic recommendations in this document.
|
||
- **Potassium citrate** (supplement) — metabolised to potassium bicarbonate, effectively alkalinises urine without sodium load. Also used clinically to prevent kidney stones.
|
||
- **Potassium bicarbonate** (supplement) — directly provides bicarbonate. Same effect, no sodium.
|
||
- **Sodium bicarbonate (baking soda)** — ¼ to ½ teaspoon in water effectively alkalinises urine. Used clinically for uric acid kidney stones and to enhance excretion of certain drugs (e.g. salicylate overdose). *Caveat:* significant sodium load (~630 mg Na per ½ teaspoon). Not ideal for those watching sodium intake or with hypertension. Potassium bicarbonate or citrate are preferred alternatives.
|
||
- **Stay well hydrated** — more urine output = more fluoride excreted. Simple renal physiology.
|
||
- **Maintain kidney health** — the kidneys are the primary excretion route. Impaired GFR increases fluoride retention. People with chronic kidney disease accumulate fluoride disproportionately.
|
||
|
||
**Protecting vulnerable systems despite exposure:**
|
||
- **Iodine sufficiency** (150-300 mcg/day from diet or supplement) — counteracts fluoride's competitive inhibition at the thyroid NIS transporter. Does not remove fluoride, but helps the thyroid maintain iodine uptake despite interference. Seaweed, iodised salt, eggs, and dairy are food sources.
|
||
- **Selenium sufficiency** (100-200 mcg/day, or 1-2 Brazil nuts) — supports the selenoenzyme deiodinases (D1, D2) that fluoride inhibits, and supports glutathione peroxidase (GPx) against fluoride-induced oxidative stress. Especially important if fluoride exposure is ongoing.
|
||
- **NAC or glycine** (glutathione precursors) — glutathione is depleted by fluoride-induced oxidative stress. Replenishing it mitigates downstream oxidative damage. Does not increase fluoride excretion itself but protects against its effects.
|
||
|
||
**What does NOT work:**
|
||
- **"Fluoride chelation"** — fluoride is an anion (F⁻), not a metal cation. It doesn't form coordinate bonds with chelating agents like EDTA or DMSA. It's incorporated into the hydroxyapatite crystal lattice. There is no chelation shortcut.
|
||
- **Boron for fluoride excretion** — theoretically can form tetrafluoroborate (BF₄⁻), but the evidence is essentially one rat study and an untraceable claim. Unproven.
|
||
- **Liver "detox" protocols** — the liver does not metabolise fluoride. F⁻ is excreted unchanged by the kidneys. Liver support has no mechanistic basis for fluoride clearance specifically.
|
||
|
||
**Realistic timeline for clearing accumulated fluoride:**
|
||
- Soft tissue fluoride clears relatively quickly once intake stops (weeks to months).
|
||
- Skeletal fluoride (99% of body burden) has a half-life of 8-20 years. After eliminating intake and optimising excretion, roughly one half-life to reduce bone burden by 50%. This is a years-to-decades process. The priority is stopping ongoing intake rather than trying to accelerate excretion.
|
||
|
||
**Does Vitamin K2 help?**
|
||
K2 activates matrix Gla protein (MGP), which inhibits ectopic soft-tissue calcification. Since fluoride accumulates in calcified deposits (including the pineal gland), K2 might reduce future soft-tissue fluoride deposition by preventing new calcification. This is mechanistically plausible but unproven — no studies have directly tested K2 against fluoride accumulation. K2 would not mobilise fluoride from existing fluorapatite (which is more thermodynamically stable than hydroxyapatite). K2 is worth taking for its established benefits (calcium metabolism, cardiovascular health, synergy with vitamins D and A), but the fluoride-specific claim remains speculative.
|
||
|
||
### 1.2 Seed Oils (Omega-6 PUFAs)
|
||
|
||
The single most important dietary toxin to eliminate. Covered extensively in METABOLISM_AND_AGING.md (Sections 3-5) and both FAT_LOSS guides. In brief: seed oils (soybean, corn, sunflower, safflower, canola, grapeseed) are incorporated into cell membranes and mitochondrial cardiolipin, where they undergo lipid peroxidation, damage the electron transport chain, and trigger inflammatory cascades. Adipose tissue PUFA half-life is 1-3 years — elimination is a multi-year process (see Section 4 below).
|
||
|
||
### 1.3 Endocrine Disruptors
|
||
|
||
A category of environmental chemicals that interfere with hormone signalling. Relevant to the hormonal aging patterns described in METABOLISM_AND_AGING.md Section 8.
|
||
|
||
**Key sources:**
|
||
- **Chemical sunscreens** (oxybenzone, avobenzone, octocrylene) — systemically absorbed, estrogenic and anti-androgenic. Use mineral sunscreen (zinc oxide) if needed, or build a base tan gradually. See PLAN.md Section 15.5.
|
||
- **BPA/BPS** (plastics, can linings, thermal receipt paper) — estrogenic. Use glass or stainless steel containers. Avoid heating food in plastic.
|
||
- **Phthalates** (fragranced products, soft plastics, vinyl) — anti-androgenic. Choose fragrance-free personal care products.
|
||
- **Phytoestrogens** (unfermented soy, flaxseed, beer/hops) — mimic estrogen at cellular receptors. Excess estrogenic signalling promotes fat storage, inflammation, and cancer risk in both sexes. See Section 3 below and METABOLISM_AND_AGING.md Section 13.2.
|
||
- **PFAS** ("forever chemicals" — non-stick cookware, waterproof clothing, food packaging) — endocrine disruption, immunotoxicity, extremely persistent. Avoid non-stick cookware (use cast iron, stainless steel, or enamelled); filter water (activated carbon does remove PFAS, unlike fluoride).
|
||
|
||
### 1.4 Heavy Metals
|
||
|
||
- **Mercury** — primarily from large predatory fish (tuna, swordfish, shark, king mackerel). Choose smaller fish (sardines, anchovies, mackerel, wild salmon) for omega-3 with less mercury. Dental amalgam fillings are another significant source.
|
||
- **Lead** — old paint, old plumbing, some imported ceramics and spices. Test home water if pipes are pre-1986.
|
||
- **Cadmium** — cigarette smoke, some fertilisers (taken up by crops), shellfish from polluted waters.
|
||
- **Arsenic** — rice (especially brown rice, which retains the arsenic-concentrating bran), some well water. Rinsing and cooking rice in excess water reduces arsenic content.
|
||
|
||
---
|
||
|
||
## 2. Water Quality
|
||
|
||
Water quality deserves its own section because it's the delivery vehicle for several of the toxins above, and because filtration is one of the highest-leverage single interventions available.
|
||
|
||
### 2.1 What's in Tap Water
|
||
|
||
Beyond fluoride (Section 1.1), municipal tap water may contain:
|
||
- **Chlorine/chloramine** — disinfection byproducts (trihalomethanes, haloacetic acids) are associated with bladder cancer risk. Carbon filters remove these effectively.
|
||
- **Pharmaceutical residues** — trace amounts of hormones (from contraceptive pills), antidepressants, antibiotics, and other drugs that pass through wastewater treatment. Poorly studied at trace levels but biologically active compounds by definition.
|
||
- **Microplastics** — ubiquitous in tap water. Health effects at current exposure levels are unknown but concerning given their ability to carry absorbed chemicals and their endocrine-disrupting properties.
|
||
- **PFAS** — widespread contamination from industrial use, firefighting foam. Extremely persistent ("forever chemicals").
|
||
- **Heavy metals** — lead from old pipes, copper from plumbing, arsenic in some groundwater.
|
||
- **Pesticide/herbicide residues** — atrazine (endocrine disruptor), glyphosate, and others depending on region.
|
||
|
||
### 2.2 Filtration Methods
|
||
|
||
| Method | Removes Fluoride? | Removes Chlorine? | Removes Heavy Metals? | Removes PFAS? | Removes Pharmaceuticals? | Cost | Notes |
|
||
|--------|:-:|:-:|:-:|:-:|:-:|------|-------|
|
||
| **Distillation** | Yes (~99%+) | Yes | Yes | Yes | Most | Moderate (energy cost) | Most thorough; removes essentially everything. Slow throughput. |
|
||
| **Reverse Osmosis** | Yes (~90-95%) | Yes | Yes | Yes | Most | Moderate (filter replacement) | Very effective broad-spectrum. Wastes some water. |
|
||
| **Activated Alumina** | Yes (~90%) | No | No | No | No | Low | Fluoride-specific. Usually combined with carbon. |
|
||
| **Activated Carbon** (Brita, etc.) | **No** | Yes | Some | Yes (partial) | Some | Low | Good for taste/chlorine. Does NOT remove fluoride. |
|
||
| **Bone Char** | Yes (partial) | No | Some | No | No | Low-moderate | Traditional method; variable effectiveness. |
|
||
|
||
**Recommendation:** Distillation or reverse osmosis for drinking and cooking water. These handle fluoride plus the broadest range of other contaminants. If budget is a concern, an RO system under the kitchen sink is a practical compromise.
|
||
|
||
---
|
||
|
||
## 3. Food Preparation and Anti-Nutrients
|
||
|
||
Many otherwise nutritious foods contain compounds that impair mineral absorption, suppress thyroid function, damage the gut lining, or disrupt hormonal balance. The solution is rarely to avoid these foods entirely — it's to prepare them correctly.
|
||
|
||
### 3.1 Goitrogens — Cook Your Cruciferous Vegetables
|
||
|
||
**The problem:** Raw cruciferous vegetables (broccoli, kale, cabbage, Brussels sprouts, cauliflower, bok choy) contain glucosinolates that convert to thiocyanates and isothiocyanates. Thiocyanates competitively inhibit thyroid iodine uptake at the NIS transporter — the same transporter fluoride interferes with (Section 1.1). This directly suppresses thyroid function and metabolic rate.
|
||
|
||
**The tension:** These same vegetables produce sulforaphane, one of the most potent Nrf2 activators known. Sulforaphane triggers the body's own antioxidant and detoxification gene expression — genuinely beneficial for longevity (see Section 8 on hormesis).
|
||
|
||
**The resolution: cook them.** Cooking substantially reduces goitrogen content while retaining sulforaphane. Light steaming is the optimal preparation method. This gives you the Nrf2 activation without the thyroid suppression.
|
||
|
||
**Broccoli sprouts** (3-day-old) are a special case — they contain very high sulforaphane but minimal goitrogens (the glucosinolate profile is different from mature plants). These can be eaten raw in small amounts as a concentrated sulforaphane source.
|
||
|
||
### 3.2 Oxalates — Don't Rely on Spinach for Minerals
|
||
|
||
**The problem:** High-oxalate foods (spinach, Swiss chard, beet greens, rhubarb, almonds) contain oxalic acid that binds calcium, iron, zinc, and magnesium in the gut, forming insoluble oxalate salts that pass through unabsorbed. Spinach is often cited as iron-rich, but its calcium absorption is ~5% vs ~30% from dairy. Its iron and zinc are similarly poorly bioavailable.
|
||
|
||
**Why this matters for the framework:** The thyroid support strategy (METABOLISM_AND_AGING.md Section 6) depends on adequate iron (for deiodinases and TPO), zinc (for thyroid receptor function), and selenium. The mitochondrial support strategy depends on magnesium (ATP exists as Mg-ATP). Relying on high-oxalate foods for these minerals undermines both strategies.
|
||
|
||
**Practical guidance:**
|
||
- Prefer low-oxalate greens for salads: romaine, cos, butter lettuce, arugula, watercress
|
||
- If eating high-oxalate vegetables, cook them — cooking + discarding the cooking water reduces oxalate content by 30-90%
|
||
- Don't count spinach as a meaningful source of calcium, iron, or zinc in your diet
|
||
- Consider supplementation for minerals if your diet is heavily plant-based (bioavailability from plant sources is generally lower)
|
||
|
||
### 3.3 Phytates — Soak, Sprout, or Ferment Grains and Legumes
|
||
|
||
**The problem:** Phytic acid (inositol hexaphosphate) in grains, legumes, nuts, and seeds chelates iron, zinc, calcium, and magnesium, reducing their bioavailability by 50-80%. Whole grains are the worst offenders — the phytate is concentrated in the bran.
|
||
|
||
**Traditional solutions that work:**
|
||
- **Soaking** (8-24 hours in water) activates phytase enzymes that break down phytates
|
||
- **Sprouting** extends the phytase action further
|
||
- **Fermenting** (sourdough bread, traditional dosas, fermented porridges) dramatically reduces phytate content — this is why sourdough bread is nutritionally superior to regular bread
|
||
- **White rice** has had the bran (and most phytates) removed — it's a perfectly fine staple carbohydrate despite being "refined"
|
||
- **Pressure cooking** beans and legumes is particularly effective
|
||
|
||
### 3.4 Lectins — Cook Your Beans Properly
|
||
|
||
**The problem:** Raw or undercooked legumes (especially kidney beans, soybeans) contain lectins that can damage intestinal epithelial cells, impair gut barrier integrity, and trigger inflammatory responses. This is relevant to the gut health pillar (PLAN.md Section 14) and the broader inflammation framework.
|
||
|
||
**Solution:** Proper cooking eliminates lectin activity. Pressure cooking is the most effective method. Canned beans are already fully cooked. The issue is specifically with undercooked dried beans — a pot of beans that hasn't simmered long enough can cause genuine GI distress.
|
||
|
||
### 3.5 Phytoestrogens — Minimise Unfermented Soy, Flaxseed, and Beer
|
||
|
||
**The problem:** Phytoestrogens mimic estrogen at cellular receptors. This is directly relevant to the hormonal aging pattern in METABOLISM_AND_AGING.md Section 8.2, where excess estrogen is identified as pro-aging in both sexes:
|
||
- **In males:** Aromatase converts testosterone to estradiol. Additional estrogenic input from diet accelerates this shift, driving visceral and chest fat accumulation, reduced libido, and increased cancer risk.
|
||
- **In females:** Estrogen dominance relative to declining progesterone drives weight gain, fluid retention, fibroids, endometriosis, and increased breast cancer risk.
|
||
|
||
**Key sources:**
|
||
- **Unfermented soy** (soy milk, tofu, soy protein isolate, edamame) — contains isoflavones (genistein, daidzein) that bind estrogen receptors. The most concentrated dietary phytoestrogen source.
|
||
- **Flaxseed** — contains very high levels of lignans, converted to enterolactone (a potent phytoestrogen) by gut bacteria.
|
||
- **Beer** — hops contain 8-prenylnaringenin, one of the most potent phytoestrogens known. The "beer belly" may be partly estrogenic, not purely caloric.
|
||
|
||
**Nuance:** Fermented soy (natto, tempeh, miso) has partially degraded isoflavones and provides unique benefits — vitamin K2 from natto, spermidine, beneficial bacteria. Use in moderation rather than avoiding entirely.
|
||
|
||
---
|
||
|
||
## 4. The Seed Oil Elimination Timeline
|
||
|
||
Eliminating seed oils from the diet is the single most important dietary change (see METABOLISM_AND_AGING.md Sections 3-5). But it's important to understand the timeline — this is not a quick fix.
|
||
|
||
### 4.1 The Biology of PUFA Turnover
|
||
|
||
When you eat seed oils, the polyunsaturated fatty acids (PUFAs) are incorporated into:
|
||
- **Cell membranes** — turnover varies by tissue (red blood cells ~120 days, other cells weeks to months)
|
||
- **Mitochondrial cardiolipin** — the critical phospholipid that stabilises ETC complexes. PUFA-rich cardiolipin is vulnerable to peroxidation, impairing oxidative phosphorylation.
|
||
- **Adipose tissue** — the deep reservoir. Adipose tissue PUFA has a half-life of **1-3 years**. Even after completely eliminating dietary seed oils, you will be releasing stored PUFAs from fat tissue for years as you metabolise that fat.
|
||
|
||
### 4.2 The Transition Period
|
||
|
||
During the first 1-3 years of seed oil elimination, you are in a transition period where stored PUFAs are still being mobilised from adipose tissue and incorporated into newly forming membranes. This is why:
|
||
|
||
- **Vitamin E supplementation** (200-400 IU/day, mixed tocopherols — NOT alpha-tocopherol alone) is recommended during this period. Vitamin E is the primary lipid-soluble chain-breaking antioxidant in cell membranes — it intercepts lipid peroxyl radicals and interrupts the peroxidation chain reaction. It's protecting the PUFAs that are still in your membranes while they're being gradually replaced with more stable fats.
|
||
- **Fat loss during this period** is actually beneficial — you're literally burning off stored PUFAs and excreting the oxidation products. The fat that replaces it (if you're eating saturated/monounsaturated fats) will be more oxidation-resistant.
|
||
- **Don't panic about perfection** — you can't avoid every trace of PUFA. The goal is to shift the ratio dramatically. Going from the typical 15-25% PUFA membrane composition toward 5-10% is the major win.
|
||
|
||
### 4.3 Cooking Fat Hierarchy
|
||
|
||
Not all animal fats are equal. The critical distinction is between ruminant and monogastric animals:
|
||
|
||
| Fat Source | PUFA Content | Why |
|
||
|-----------|-------------|-----|
|
||
| **Beef/lamb tallow** | ~3-4% | Rumen biohydrogenates dietary PUFAs into saturated fat |
|
||
| **Butter/ghee** | ~3-4% | Same ruminant mechanism |
|
||
| **Coconut oil** | ~2% | Naturally very low PUFA (plant but tropical) |
|
||
| **Olive oil (EVOO)** | ~10% (mostly MUFA) | Predominantly monounsaturated; stable at low-medium heat |
|
||
| **Pasture-raised lard** | ~8-10% | Better than conventional but still higher than ruminant |
|
||
| **Conventional lard** | ~15-25% | Reflects corn/soy feed — NOT a good seed oil replacement |
|
||
| **Chicken fat** | ~20-25% | Same issue as conventional lard |
|
||
| **Seed oils** | ~50-70%+ | The worst; also routinely heated to extreme temperatures |
|
||
|
||
**Use ruminant fats (tallow, butter, ghee) and coconut oil for cooking.** EVOO for dressing and low-heat cooking. Avoid conventional lard and chicken fat as primary cooking fats.
|
||
|
||
### 4.4 Fish Oil Supplements — Caution
|
||
|
||
Omega-3 from whole fish (sardines, wild salmon, mackerel) is protected by the fish's own antioxidant matrix (astaxanthin, selenium, vitamin E). Standard fish oil capsules, however, are frequently oxidised:
|
||
- Studies from New Zealand, South Africa, Norway, Canada, and the US found the majority of retail fish oil supplements exceeded voluntary oxidation limits
|
||
- Oxidised omega-3 may negate or reverse the anti-inflammatory benefit
|
||
- If supplementing, demand third-party oxidation testing (IFOS certification), triglyceride form, and refrigerated storage
|
||
- **Prefer reducing omega-6 intake** (eliminating seed oils) over adding more omega-3. This improves the ratio by shrinking the numerator rather than adding more oxidation-vulnerable PUFAs.
|
||
|
||
---
|
||
|
||
## 5. Sugar, Glucose, and Metabolic Rate
|
||
|
||
The conventional longevity advice to "minimise sugar at all costs" deserves careful examination. The framework argues that glucose is the preferred and cleanest mitochondrial fuel, and that chronic glucose restriction may be more harmful than moderate sugar intake.
|
||
|
||
### 5.1 Glucose Is the Preferred Fuel
|
||
|
||
**Cleaner mitochondrial energetics:**
|
||
- Glucose oxidation via glycolysis → pyruvate → TCA cycle produces a NADH-dominant electron profile for the ETC
|
||
- Fat oxidation (beta-oxidation) produces a higher FADH2/NADH ratio
|
||
- FADH2 feeds electrons to Complex II (succinate dehydrogenase), which can drive **reverse electron transport (RET) at Complex I** — one of the largest sources of mitochondrial superoxide (ROS)
|
||
- In other words: burning fat generates *more* oxidative stress per ATP produced than burning glucose
|
||
- This is established mitochondrial bioenergetics, not speculation
|
||
|
||
**More CO2 production:**
|
||
- Glucose oxidation has a respiratory quotient (RQ) of 1.0 — maximum CO2 produced per O2 consumed
|
||
- Fat oxidation has an RQ of ~0.7 — 30% less CO2
|
||
- CO2 is essential for oxygen delivery via the Bohr effect (see Section 10)
|
||
- A person burning primarily fat produces less CO2 → hemoglobin holds oxygen tighter → tissues receive less oxygen despite identical blood oxygen saturation
|
||
|
||
**Gluconeogenesis is a stress state:**
|
||
- When dietary glucose is insufficient, the body must produce it via gluconeogenesis in the liver
|
||
- This requires cortisol — the primary catabolic stress hormone
|
||
- Cortisol breaks down muscle protein to liberate amino acids (alanine, glutamine) as gluconeogenic substrates
|
||
- Chronic gluconeogenesis = chronic cortisol elevation = muscle wasting, bone loss, immune suppression, hippocampal atrophy, visceral fat accumulation
|
||
- This is one of the core arguments against chronic low-carb and ketogenic diets (see Section 18.3)
|
||
|
||
### 5.2 The Randle Cycle — Fat May Cause "Sugar Problems"
|
||
|
||
The Randle cycle describes competition between glucose and fatty acids for cellular oxidation:
|
||
- High circulating free fatty acids (from lipolysis or dietary fat, especially PUFAs from seed oils) inhibit glucose oxidation at multiple enzymes: pyruvate dehydrogenase, phosphofructokinase, hexokinase
|
||
- This causes insulin resistance and impaired glucose clearance
|
||
- Much of the "sugar causes metabolic disease" narrative may actually be confounding sugar with seed oil consumption, which has increased ~100x in the past century and directly impairs glucose metabolism via this mechanism
|
||
- Removing seed oils may restore healthy glucose metabolism, making sugar intake far less problematic
|
||
|
||
### 5.3 Glycation — Real but Context-Dependent
|
||
|
||
Advanced glycation end-products (AGEs) are a legitimate concern:
|
||
- Glucose and fructose react non-enzymatically with proteins (Maillard reaction)
|
||
- This cross-links collagen, crystallin, and other long-lived proteins
|
||
- AGE accumulation contributes to arterial stiffening, cataracts, kidney damage, skin aging
|
||
|
||
**However**, glycation rate depends on blood glucose *concentration and exposure time*, not simply on dietary sugar intake:
|
||
- Someone with a high metabolic rate who rapidly clears glucose may have lower glycation despite higher sugar intake
|
||
- Someone with insulin resistance (potentially caused by seed oils via the Randle cycle) may have higher glycation despite moderate sugar intake
|
||
- The key variable is glucose clearance efficiency (metabolic rate, insulin sensitivity, physical activity) rather than total grams of sugar consumed
|
||
- Supporting metabolic rate, exercising, and eliminating seed oils may be more protective against glycation than restricting sugar
|
||
|
||
### 5.4 Fructose in Context
|
||
|
||
Fructose is often demonised, but in the context of whole sucrose (glucose + fructose) or whole fruit:
|
||
- Fructose activates hepatic glucokinase, which *enhances* glucose utilisation
|
||
- It replenishes liver glycogen efficiently
|
||
- Problems attributed to fructose (fatty liver, lipogenesis) may primarily occur in the context of already-full liver glycogen, excess caloric intake, and impaired metabolic function — not as an inherent property of fructose
|
||
- **Fruit** (containing fructose + fibre + micronutrients + water) is consistently associated with health benefits across virtually all epidemiological studies. No credible evidence shows harm from eating whole fruit.
|
||
- Honey is a highly digestible glucose + fructose source and has been consumed by humans for hundreds of thousands of years
|
||
|
||
### 5.5 Practical Position
|
||
|
||
1. **Do not treat sugar as inherently toxic.** The "low-glycemic everything" approach may be counterproductive if it leads to chronic fat-burning, elevated cortisol, and impaired metabolic rate.
|
||
2. **Eat adequate carbohydrate** from whole food sources — fruit, root vegetables (potatoes, sweet potatoes, carrots), rice, honey, well-cooked grains.
|
||
3. **Focus on glucose clearance** (exercise, metabolic rate, insulin sensitivity, seed oil elimination) rather than sugar avoidance.
|
||
4. **Cycle between fed and fasted states.** Adequate glucose during eating windows (supporting metabolic rate, preventing cortisol-driven catabolism), with periodic fasting windows for autophagy activation. Not chronic restriction, not chronic excess.
|
||
5. **The real enemy is seed oils**, not sugar. Eliminate PUFAs first — sugar becomes far less problematic when glucose metabolism is working properly.
|
||
|
||
---
|
||
|
||
## 6. Cholesterol and Saturated Fat — Essential, Not Harmful
|
||
|
||
Conventional dietary advice demonises saturated fat and cholesterol. This directly contradicts the bioenergetic framework because (a) saturated fat is the most oxidation-resistant dietary fat, and (b) cholesterol is the precursor to virtually every steroid hormone and to vitamin D.
|
||
|
||
### 6.1 The Diet-Heart Hypothesis Has Weakened
|
||
|
||
The claim that saturated fat raises cholesterol which causes heart disease was proposed by Ancel Keys in the 1950s-60s. Modern evidence has substantially undermined it:
|
||
|
||
- **Siri-Tarino et al. (2010, AJCN):** Meta-analysis of 21 prospective cohort studies (347,747 subjects) — "no significant evidence that dietary saturated fat is associated with an increased risk of CHD or CVD"
|
||
- **Chowdhury et al. (2014, Annals of Internal Medicine):** Meta-analysis — no association between saturated fat and cardiovascular disease
|
||
- **PURE study (2017, Lancet):** 135,335 people across 18 countries — higher saturated fat intake associated with **lower** total mortality
|
||
- **Sydney Diet Heart Study (recovered data, 2013):** Replacing saturated fat with omega-6 PUFA (safflower oil) **increased** cardiovascular and all-cause mortality
|
||
- **Minnesota Coronary Experiment (recovered data, 2016):** Replacing saturated fat with corn oil lowered cholesterol but did NOT reduce mortality — trend toward increased mortality in the intervention group
|
||
- Traditional populations consuming high saturated fat (French, Masai, Tokelau) had minimal cardiovascular disease
|
||
|
||
### 6.2 Cholesterol Is Essential
|
||
|
||
Cholesterol is not a toxin to be minimised — it is a critical structural and biochemical molecule:
|
||
|
||
- **Steroid hormone precursor:** Cholesterol → pregnenolone → ALL steroid hormones (DHEA, testosterone, estradiol, progesterone, cortisol, aldosterone). The first step (cholesterol → pregnenolone via CYP11A1) occurs on the inner mitochondrial membrane and requires functional mitochondria. Suppress cholesterol → suppress pregnenolone → suppress all downstream hormones.
|
||
- **Cell membrane integrity:** Every cell membrane requires cholesterol for proper fluidity, rigidity, and signalling
|
||
- **Vitamin D synthesis:** 7-dehydrocholesterol in skin → vitamin D3 via UV exposure
|
||
- **Bile acid production:** Required for fat-soluble vitamin absorption (A, D, E, K)
|
||
- **Myelin sheath:** The brain and nervous system are cholesterol-rich; cholesterol is essential for nerve conduction
|
||
- **Lipid raft signalling:** Cholesterol-rich membrane microdomains are essential for receptor signalling
|
||
|
||
**Low cholesterol is associated with:**
|
||
- Increased all-cause mortality in elderly populations (multiple studies)
|
||
- Higher rates of depression, anxiety, and suicide
|
||
- Higher cancer mortality in some cohorts
|
||
- Impaired immune function
|
||
- Hormonal insufficiency
|
||
|
||
### 6.3 Statins — A Comprehensive Case Against
|
||
|
||
Statins (HMG-CoA reductase inhibitors) are the most widely prescribed drug class in the world, given to hundreds of millions of people. From a bioenergetic perspective, they are one of the most metabolically destructive drugs in common use.
|
||
|
||
#### 6.3.1 The Mevalonate Pathway — Statins Block Far More Than Cholesterol
|
||
|
||
HMG-CoA reductase catalyses the rate-limiting step of the mevalonate pathway — one of the most ancient and fundamental biosynthetic pathways in all eukaryotic life. Cholesterol is merely one of its many end-products. When you inhibit HMG-CoA reductase, you suppress the entire pathway:
|
||
|
||
```
|
||
Acetyl-CoA → HMG-CoA → [STATINS BLOCK HERE] → Mevalonate → Isopentenyl-PP (IPP)
|
||
|
|
||
+------ Farnesyl-PP (FPP) --------+------------+----------+
|
||
| | | |
|
||
v v v v
|
||
Squalene Dolichols Heme A Farnesylation
|
||
| (glycoprotein (Complex IV (Ras, nuclear
|
||
v synthesis) prosthetic lamins)
|
||
Cholesterol group)
|
||
→ Steroid Geranylgeranyl-PP (GGPP)
|
||
hormones |
|
||
→ Bile acids +------------+------------+
|
||
→ Vitamin D | | |
|
||
v v v
|
||
CoQ10 Vitamin K2 GG-ylation
|
||
(ETC electron (arterial (Rho, Rab,
|
||
carrier) calcification Rac, Cdc42
|
||
inhibitor) GTPases)
|
||
```
|
||
|
||
**Every branch of this pathway is suppressed by statins.** The collateral damage:
|
||
|
||
**1. Coenzyme Q10 (Ubiquinone)** — The most critical casualty. CoQ10 is the mobile electron carrier between Complexes I/II and Complex III in the mitochondrial electron transport chain. Without it, electrons cannot flow, protons cannot be pumped, and ATP cannot be made. It is also the only endogenously synthesised lipid-soluble antioxidant in human membranes. Statin therapy reduces plasma CoQ10 by 16-54% (Ghirlanda et al. 1993; Banach et al. 2015 meta-analysis). Muscle biopsies from statin-treated patients confirm reduced intramuscular CoQ10 (Lamperti et al. 2005, *Arch Neurol*). CoQ10 already declines naturally with age (peaking around age 20-25), so statins impose iatrogenic depletion on top of age-related decline — exactly the wrong direction for longevity.
|
||
|
||
**2. Heme A** — The prosthetic group of Complex IV (cytochrome c oxidase), synthesised from heme B via farnesylation using farnesyl pyrophosphate from the mevalonate pathway. Complex IV is the terminal step of the ETC — it reduces oxygen to water. Reduced heme A synthesis impairs Complex IV assembly and function, hitting the very last step of oxidative phosphorylation.
|
||
|
||
**3. Dolichols** — Long-chain polyisoprenoid alcohols required for N-linked glycosylation of proteins in the endoplasmic reticulum. Without dolichols, protein folding, cell surface receptor function, immune recognition, and lysosomal enzyme targeting are all impaired. This contributes to proteostasis dysfunction — one of the hallmarks of aging.
|
||
|
||
**4. Isoprenoids (protein prenylation)** — Small GTPases of the Ras superfamily (Rho, Rac, Cdc42, Rab) require prenylation for membrane anchoring and function. These control cytoskeletal dynamics, vesicular trafficking, immune cell function, endothelial nitric oxide production, and muscle cell maintenance. Statins deplete both farnesyl-PP and geranylgeranyl-PP, globally impairing these signalling systems.
|
||
|
||
**5. Vitamin K2 (Menaquinone-4)** — MK-4 is synthesised in human tissues by UBIAD1, which uses geranylgeranyl pyrophosphate (a mevalonate pathway product) to convert K1 to MK-4. K2 activates matrix Gla protein (MGP), the most potent endogenous inhibitor of vascular calcification. By reducing GGPP, statins may impair K2 synthesis → reduce MGP activation → *promote arterial calcification* — the very pathology they're meant to prevent. Multiple studies show statins increase coronary artery calcium scores (Saremi et al. 2012, *Diabetes Care*; Henein et al. 2015). Okuyama et al. (2015, *Expert Rev Clin Pharmacol*) argued statins stimulate atherosclerosis via this mechanism.
|
||
|
||
**6. Selenoprotein synthesis** — The incorporation of selenocysteine into selenoproteins requires isopentenylation of Sec-tRNA[Ser]Sec using isopentenyl pyrophosphate from the mevalonate pathway (Moosmann & Behl, 2004, *Lancet*). Impaired selenoprotein synthesis means reduced glutathione peroxidases (GPx — primary defence against lipid peroxidation), reduced thioredoxin reductases, and reduced iodothyronine deiodinases (D1, D2 — the enzymes that convert T4 to active T3). The irony: a drug prescribed for cardiovascular protection may simultaneously impair the antioxidant systems that protect LDL from the oxidation that actually causes atherosclerosis, AND impair thyroid function (hypothyroidism itself raises LDL).
|
||
|
||
#### 6.3.2 Mitochondrial Destruction
|
||
|
||
From a bioenergetic perspective, the mitochondrial toxicity of statins is the most damning issue. If aging is fundamentally declining cellular energy production, then any drug that impairs mitochondria is pro-aging by definition.
|
||
|
||
**How statins damage mitochondria:**
|
||
|
||
1. **CoQ10 depletion** → electrons can't flow from Complex I/II to Complex III → ETC backs up → electrons leak to oxygen → superoxide radical (O₂·⁻) production increases → oxidative stress increases
|
||
|
||
2. **Reduced ATP production** — less electron flow = less proton pumping = less ATP synthase activity. In high-energy-demand tissues (heart, muscle, brain, kidney), this creates a measurable bioenergetic deficit
|
||
|
||
3. **Heme A depletion** → impaired Complex IV → the terminal step of the ETC is crippled
|
||
|
||
4. **Increased mitochondrial ROS** → damages mitochondrial DNA (which lacks histones, has limited repair, and sits adjacent to the ROS-producing ETC) → impaired ETC protein synthesis → more ROS → the "mitochondrial vicious cycle" of aging, accelerated
|
||
|
||
5. **Direct Complex I inhibition** — lipophilic statins (simvastatin, atorvastatin, lovastatin) directly inhibit Complex I independent of CoQ10 depletion (Nadanaciva et al. 2007, *Toxicol Appl Pharmacol*)
|
||
|
||
6. **Mitochondrial membrane depolarisation** — statins induce mitochondrial swelling and membrane potential loss in muscle cells (Kaufmann et al. 2006; Sirvent et al. 2005), consistent with mitochondrial permeability transition pore opening
|
||
|
||
7. **Impaired mitochondrial biogenesis** — statins reduce PGC-1α expression in some studies, blocking the compensatory response
|
||
|
||
This is the biochemical equivalent of simultaneously reducing fuel supply, damaging the engine, disabling the maintenance system, and blocking the factory that builds new engines.
|
||
|
||
#### 6.3.3 Muscle Damage — Far Worse Than Reported
|
||
|
||
**The underreporting problem:** Clinical trials report statin muscle symptoms (SAMS) at 1-5%. Real-world studies consistently find much higher rates:
|
||
|
||
- PRIMO study (Bruckert et al. 2005): 10.5% of 7,924 patients on high-dose statins had muscular symptoms
|
||
- USAGE survey (Cohen et al. 2012): 29% of 10,000+ statin users reported musculoskeletal symptoms
|
||
- Zhang et al. (2013, *BMC Medicine*): ~25% muscle complaints in observational cohort
|
||
|
||
**Why the discrepancy?** Most statin RCTs include a "run-in" period where participants take the statin before randomisation — those who develop side effects are *excluded from the trial before it begins*. This systematically removes the most statin-intolerant patients. Additionally, trials define myopathy only by extreme CK elevation (>10x upper limit of normal), missing the much larger population with significant pain and weakness below that threshold.
|
||
|
||
**Mechanism:** The muscle damage is primarily mitochondrial — CoQ10 depletion in myofibers → energy deficit → inability to meet ATP demand for contraction → pain and weakness. Also impaired Rab-mediated membrane repair, disrupted cytoskeletal dynamics from isoprenoid depletion, and calcium dysregulation from mitochondrial dysfunction. SLCO1B1 gene polymorphisms (c.521T>C) affect statin metabolism and increase myopathy risk up to 17-fold in homozygous carriers.
|
||
|
||
**Rhabdomyolysis** — massive muscle breakdown — is rare but potentially fatal (acute kidney injury from myoglobin precipitation, hyperkalemia, cardiac arrhythmia). Cerivastatin was withdrawn from market in 2001 after 52 deaths. Risk amplified by drug interactions (CYP3A4 inhibitors), hypothyroidism, renal impairment, and advanced age.
|
||
|
||
**CoQ10 supplementation** helps in some studies (Caso et al. 2007 — 40% pain reduction with 100 mg/day) but not all, likely because: (a) CoQ10 addresses only one arm of the damage, (b) many studies used inadequate doses or oxidised ubiquinone (ubiquinol has 3-8x better bioavailability), and (c) if isoprenoid depletion and direct mitochondrial toxicity are also involved, CoQ10 alone isn't enough.
|
||
|
||
#### 6.3.4 Diabetes Risk
|
||
|
||
This is now well-established even in mainstream medicine:
|
||
|
||
- **Sattar et al. (2010, *Lancet*):** Meta-analysis of 13 trials (91,140 people) — 9% increased diabetes risk. One new diabetes case per 255 treated for 4 years.
|
||
- **Preiss et al. (2011, *JAMA*):** Intensive-dose statins increase diabetes by 12% vs moderate dose — dose-dependent.
|
||
- **WHI (Culver et al. 2012, *Arch Intern Med*):** 48% increased diabetes risk in postmenopausal women on statins.
|
||
- **METSIM (Cederberg et al. 2015, *Diabetologia*):** 46% increased diabetes risk, with 24% reduced insulin sensitivity and 12% reduced insulin secretion.
|
||
|
||
**Mechanism:** Multifactorial — CoQ10 depletion in pancreatic beta-cell mitochondria impairs glucose sensing (which depends on mitochondrial ATP production closing KATP channels); impaired Rab-mediated GLUT4 trafficking in muscle reduces insulin-stimulated glucose uptake; impaired isoprenylation disrupts insulin signalling cascades.
|
||
|
||
**The irony:** Type 2 diabetes is itself a 2-4x cardiovascular risk factor. If statins cause diabetes, some of the cardiovascular "benefit" is offset by the cardiovascular risk from statin-induced diabetes.
|
||
|
||
#### 6.3.5 Cognitive Effects
|
||
|
||
The brain contains ~25% of total body cholesterol despite being ~2% of body weight. Critically, the brain synthesises its own cholesterol — plasma LDL does not cross the blood-brain barrier (BBB). Brain cholesterol is essential for:
|
||
- Myelin sheath (70-80% lipid, cholesterol is the largest single component)
|
||
- Synapse formation (astrocyte-derived cholesterol is the rate-limiting factor — Mauch et al. 2001, *Science*)
|
||
- Lipid raft signalling (organising neurotransmitter receptors)
|
||
- Neurosteroid synthesis (allopregnanolone, DHEA, pregnenolone)
|
||
|
||
**Lipophilic statins** (simvastatin, lovastatin, atorvastatin) cross the BBB and directly inhibit brain cholesterol synthesis. The FDA added a safety warning in 2012 for memory loss, confusion, and cognitive impairment. Golomb et al. found objective cognitive deficits on neuropsychological testing during statin therapy. Muldoon et al. (2000, 2004) found impaired attention and psychomotor speed in two RCTs.
|
||
|
||
**Late-life low cholesterol** is consistently associated with increased dementia risk (Mielke et al. 2005; Honolulu-Asia Aging Study 2000). Aggressively lowering cholesterol in the elderly may accelerate cognitive decline.
|
||
|
||
#### 6.3.6 Hormonal Disruption
|
||
|
||
All steroid hormones are made from cholesterol: cholesterol → pregnenolone → DHEA → testosterone / estradiol / progesterone / cortisol / aldosterone. The rate-limiting step (CYP11A1) occurs on the inner mitochondrial membrane — so statins could impair steroidogenesis both by reducing substrate (cholesterol) AND by damaging the mitochondrial machinery that performs the conversion.
|
||
|
||
- Corona et al. (2010) meta-analysis: statins associated with reduced testosterone
|
||
- Schooling et al. (2013): Mendelian randomisation confirmed genetically-predicted lower LDL → lower testosterone
|
||
- The UCSD Statin Study (Golomb et al. 2009): double-blind RCT showing both simvastatin and pravastatin significantly worsened sexual function scores
|
||
|
||
DHEA-S — the most abundant circulating steroid and a longevity biomarker that declines ~80-90% from age 20 to 80 — may also be suppressed.
|
||
|
||
#### 6.3.7 The Clinical Trial Evidence Is Weaker Than Presented
|
||
|
||
**Relative vs absolute risk reduction — the key statistical manipulation:**
|
||
|
||
| Trial | Population | Relative risk reduction | Absolute risk reduction | NNT | All-cause mortality benefit? |
|
||
|-------|-----------|------------------------|------------------------|-----|---------------------------|
|
||
| 4S (1994) | Secondary prev, high LDL | 34% | 3.3% | 30 | Yes (best case for statins) |
|
||
| WOSCOPS (1995) | Primary prev, men | 31% | 2.4% | 42 | No |
|
||
| JUPITER (2008) | Primary prev, high CRP | 44% | 1.2% | 83 | No (stopped early) |
|
||
| ASCOT-LLA (2003) | Primary prev, hypertensive | 36% | 1.1% | 91 | No |
|
||
| ALLHAT-LLT (2002) | Primary prev (gov't funded) | — | — | — | No benefit at all |
|
||
| STAREE (2024) | Elderly >70, healthy | — | — | — | No benefit (death, dementia, or disability) |
|
||
|
||
Drug companies advertise the relative risk reduction ("reduces heart attacks by 36%!") while the absolute risk reduction is often ~1-2%. An NNT of 83-91 means treating 83-91 healthy people with a mitochondrially toxic drug for years so that 1 person avoids a non-fatal cardiovascular event — while all 83-91 are exposed to CoQ10 depletion, diabetes risk, muscle damage, and hormonal disruption.
|
||
|
||
**No primary prevention trial has shown a statistically significant all-cause mortality benefit.** The CTT Collaboration claims one by pooling primary and secondary prevention data — but the risk-benefit calculus is fundamentally different between these populations.
|
||
|
||
**Trial design problems:**
|
||
- Run-in periods that exclude intolerant patients before randomisation
|
||
- Short durations (2-5 years) that underestimate long-term mitochondrial damage
|
||
- Industry funding (Lexchin et al. 2003: industry-funded trials are 3-4x more likely to report favourable results)
|
||
- The CTT Collaboration refuses to release individual patient data for independent analysis
|
||
- ALLHAT-LLT (government-funded) found no benefit — received far less attention than industry-funded positive trials
|
||
|
||
**Women:** No primary prevention trial has shown a mortality benefit for women. Even in secondary prevention, the female subgroup mortality benefit is not statistically significant. Yet statins are widely prescribed to women — including postmenopausal women in whom the WHI showed a 48% diabetes increase.
|
||
|
||
**Elderly (>70):** The PROSPER trial (2002, specifically designed for ages 70-82) reduced coronary events but increased cancer mortality such that all-cause mortality was unchanged. The STAREE trial (2024, *NEJM*) — atorvastatin 40mg in 8,000+ healthy adults >70 — found **no benefit** for death, dementia, or disability-free survival. Combined with the cholesterol paradox (higher cholesterol = lower mortality in the elderly), prescribing statins to healthy elderly people is difficult to justify.
|
||
|
||
#### 6.3.8 What Actually Causes Atherosclerosis
|
||
|
||
If not total LDL cholesterol, then what?
|
||
|
||
**The response-to-injury model (Ross, 1999, *NEJM*):**
|
||
|
||
1. **Endothelial damage comes first** — from oxidative stress, glycation (AGEs from hyperglycaemia), seed oil metabolites (4-HNE from linoleic acid peroxidation), homocysteine, hypertension, or toxins
|
||
2. **Oxidised LDL accumulates** — native (unoxidised) LDL is NOT avidly taken up by macrophages. Only oxidised LDL (oxLDL) is recognised by scavenger receptors (SR-A, CD36) and triggers foam cell formation
|
||
3. **What oxidises LDL?** The fatty acid composition of LDL particles is the primary determinant. LDL enriched in linoleic acid (from seed oils) is highly susceptible — each PUFA double bond exponentially increases oxidisability. LDL enriched in saturated fat is resistant.
|
||
4. **Foam cells and inflammation** → plaque growth → rupture → clot → heart attack/stroke
|
||
|
||
**The key insight:** The relevant question is not "how much LDL is in your blood?" but "how oxidisable is your LDL?" The dramatic increase in linoleic acid consumption — from ~2-3% of calories in 1900 to 7-8%+ today via seed oils — has made our LDL particles far more oxidation-prone, coinciding precisely with the cardiovascular disease epidemic.
|
||
|
||
**Evidence:** Ramsden et al. (2013, 2016) showed that replacing saturated fat with seed oils *increased* mortality. Oxidised linoleic acid metabolites (OXLAMs: 9-HODE, 13-HODE) are the most abundant oxidised fatty acids in atherosclerotic plaques. 4-HNE (from linoleic acid peroxidation) is directly toxic to endothelial cells.
|
||
|
||
#### 6.3.9 Better Alternatives for Cardiovascular Protection
|
||
|
||
Instead of damaging mitochondria to lower a number (LDL) that may not be the actual problem, address the root causes:
|
||
|
||
1. **Eliminate seed oils** — reduces LDL linoleic acid content → dramatically reduces LDL oxidisability → directly addresses the oxidised-LDL mechanism. More important than any drug.
|
||
|
||
2. **Vitamin K2** — activates matrix Gla protein → prevents and may reverse arterial calcification. Rotterdam Study: highest K2 intake had 57% lower cardiac mortality. Dose: MK-7 180-360 mcg/day or MK-4 15-45 mg/day.
|
||
|
||
3. **Magnesium** — natural calcium channel blocker, vasodilator, anti-arrhythmic, anti-inflammatory. Required for Mg-ATP (the actual form of ATP in the body). 50-80% of the Western population is deficient. Meta-analyses: 22% lower heart failure risk per 100mg/day increase (Qu et al. 2013). Dose: 400-800 mg/day glycinate/taurate/malate.
|
||
|
||
4. **CoQ10/Ubiquinol** — supports the ETC directly. The Q-SYMBIO trial (Mortensen et al. 2014) showed CoQ10 300 mg/day reduced cardiovascular mortality by 43% in heart failure patients — a larger effect than any statin trial, and it *supports* rather than *damages* mitochondria.
|
||
|
||
5. **Thyroid optimisation** — hypothyroidism (including subclinical) is a major cause of elevated LDL. T3 directly upregulates hepatic LDL receptor expression. Many patients prescribed statins for "high cholesterol" may actually need thyroid correction, not a mitochondrial toxin. Every patient with elevated LDL should have TSH, free T4, free T3, and thyroid antibodies measured first.
|
||
|
||
6. **Aspirin (low-dose, 75-100 mg)** — anti-thrombotic (inhibits TXA2), anti-inflammatory (produces aspirin-triggered lipoxins), antiserotonergic. If statins' benefit is actually from their anti-inflammatory "pleiotropic" effects, aspirin achieves this without destroying mitochondria.
|
||
|
||
7. **Niacin (nicotinic acid)** — the only lipid-modifying agent ever shown to reduce all-cause mortality as monotherapy (Coronary Drug Project, 15-year follow-up: 11% mortality reduction). Raises HDL, lowers triglycerides, lowers Lp(a), shifts small dense LDL to large buoyant LDL. The negative AIM-HIGH and HPS2-THRIVE trials tested niacin *on top of statins* (not as monotherapy) and used problematic formulations.
|
||
|
||
8. **Niacinamide / NAD+ support** — precursor to NAD+ via the salvage pathway. NAD+ is essential for sirtuin activity, DNA repair, and Complex I function. Supports the very mitochondrial pathways statins destroy.
|
||
|
||
#### 6.3.10 Summary Position
|
||
|
||
**For primary prevention (no existing heart disease):** The evidence does not support statins. No all-cause mortality benefit, small absolute risk reductions offset by substantial harms (mitochondrial damage, diabetes, myopathy, cognitive effects, hormonal disruption). The better approach is to address root causes: eliminate seed oils, optimise thyroid, supplement K2/Mg/CoQ10, exercise, manage blood sugar.
|
||
|
||
**For women in primary prevention:** No mortality benefit in any trial. Combined with 48% diabetes increase (WHI), the harm likely outweighs any benefit.
|
||
|
||
**For healthy elderly (>70):** No benefit (STAREE 2024). Increased cancer mortality (PROSPER). Cholesterol paradox (higher cholesterol = lower mortality). Maximum vulnerability to side effects (lowest baseline CoQ10, most sarcopenia risk, most cognitive vulnerability). Statins should be deprescribed in healthy elderly.
|
||
|
||
**For secondary prevention (post-heart attack):** This is where the strongest case exists. The 4S trial showed genuine all-cause mortality benefit (NNT ~30). However, even here: (a) the benefit may be anti-inflammatory rather than cholesterol-lowering, (b) CoQ10 co-supplementation should be mandatory, (c) the damaged heart is particularly vulnerable to CoQ10 depletion, and (d) the Q-SYMBIO trial showed CoQ10 alone reduced cardiovascular mortality by 43%.
|
||
|
||
**If currently on statins:** Do not stop without medical guidance (abrupt cessation may carry rebound risk). But: supplement CoQ10 (200-400 mg/day ubiquinol) at minimum, discuss with your doctor whether the statin is actually indicated given your individual risk profile, and adopt the root-cause interventions above regardless.
|
||
|
||
---
|
||
|
||
## 7. Supplementation Rationale
|
||
|
||
The full supplementation stack is in METABOLISM_AND_AGING.md Section 13.3. This section explains the *why* behind the key supplements in the context of environmental toxin exposure and metabolic support.
|
||
|
||
### 7.1 Thyroid Support Stack
|
||
|
||
The thyroid sets metabolic rate for the entire body (METABOLISM_AND_AGING.md Section 6). Multiple modern exposures conspire to suppress it:
|
||
|
||
| Supplement | Why It's Needed | Dose Range |
|
||
|-----------|----------------|------------|
|
||
| **Selenium** | Deiodinases (T4→T3) are selenoenzymes; fluoride inhibits them; selenium supports function | 100-200 mcg/day (or 1-2 Brazil nuts) |
|
||
| **Iodine** | Raw material for thyroid hormones; fluoride competes at NIS transporter; goitrogens in raw cruciferous also interfere | 150-300 mcg/day |
|
||
| **Zinc** | Required for thyroid hormone receptor function | 15-30 mg/day (balance with copper 2-4 mg) |
|
||
| **Iron** | Required for deiodinase activity and TPO | Test before supplementing; excess is harmful |
|
||
| **Vitamin A (retinol)** | Required for thyroid hormone signalling at the nuclear receptor | 5000-10000 IU/day (from liver or supplement) |
|
||
| **Adequate carbohydrate** | Low insulin shifts T4→rT3 (inactive) instead of T3 (active) | Not a supplement — eat enough carbs from whole food |
|
||
|
||
### 7.2 Mitochondrial Support Stack
|
||
|
||
Mitochondria are the primary target of aging and of several environmental toxins (fluoride, seed oils, metformin). Supporting them is foundational.
|
||
|
||
| Supplement | Why It's Needed | Dose Range |
|
||
|-----------|----------------|------------|
|
||
| **Magnesium** (glycinate/taurate) | ATP exists as Mg-ATP; cofactor for 300+ enzymes; widespread deficiency | 200-600 mg elemental/day |
|
||
| **B-complex** (active forms) | ETC cofactors: B1→PDH, B2→FAD (Complex II), B3→NAD (Complex I), B5→CoA | Per label |
|
||
| **CoQ10 / Ubiquinol** | ETC electron carrier (Complex I→III, II→III); declines with age; essential if on statins | 100-300 mg/day |
|
||
| **Creatine** | Phosphocreatine shuttle maintains ATP/ADP ratio; neuroprotective | 3-5 g/day |
|
||
| **Taurine** | Literally incorporated into mitochondrial tRNAs (tau-modification of wobble uridine) — required for proper translation of all 13 ETC subunits encoded by mtDNA. Declines ~80% from youth to old age. 10-12% lifespan extension in middle-aged mice (Singh et al. 2023, *Science*). Also: bile acid conjugation, cardiac function, anti-inflammatory (taurine chloramine). See SUPPLEMENTS.md for full analysis. | 3-6 g/day |
|
||
|
||
### 7.3 Antioxidant Defence (Endogenous, Not Exogenous)
|
||
|
||
The goal is to support the body's own antioxidant systems rather than flood it with exogenous scavengers (see Section 8 for why exogenous antioxidant supplements fail).
|
||
|
||
| Supplement | System Supported | Notes |
|
||
|-----------|-----------------|-------|
|
||
| **Glycine** (or bone broth/gelatin) | Glutathione synthesis (glycine + cysteine + glutamate) | 5-10 g/day; also balances tryptophan/serotonin (Section 17.2) |
|
||
| **NAC** (N-acetylcysteine) | Glutathione synthesis (cysteine donor) | 600-1200 mg/day; do NOT take around exercise (blocks hormetic signal) |
|
||
| **Selenium** | Glutathione peroxidase (GPx) — selenoenzyme | 100-200 mcg/day (covered above) |
|
||
| **Zinc + Copper + Manganese** | Superoxide dismutase (SOD) isoforms | From diet and/or supplement |
|
||
| **Vitamin E** (mixed tocopherols) | Membrane antioxidant — protects remaining PUFAs during seed oil elimination transition | 200-400 IU/day during transition period |
|
||
|
||
### 7.4 Bone Broth, Gelatin, and the Amino Acid Balance
|
||
|
||
Bone broth and gelatin deserve special mention because they serve multiple purposes simultaneously:
|
||
|
||
**The amino acid argument:** Modern diets eat almost exclusively muscle meat, which is high in tryptophan (the serotonin precursor). Gelatin and collagen contain virtually no tryptophan — they are rich in glycine, proline, and hydroxyproline. Traditional diets consumed the whole animal (muscle, organs, skin, bones, connective tissue), naturally balancing tryptophan with glycine. This balance matters because chronically elevated serotonin is anti-metabolic, pro-fibrotic, and promotes fat storage (see Section 17.2).
|
||
|
||
**What gelatin/bone broth provides:**
|
||
- **Glycine** — glutathione synthesis (antioxidant defence), methylation reactions, collagen synthesis, improved sleep quality, anti-inflammatory, opposes serotonin's fibrotic effects
|
||
- **Proline and hydroxyproline** — collagen and connective tissue building blocks
|
||
- **Glutamine** — primary fuel for enterocytes (intestinal epithelial cells), supports gut barrier integrity
|
||
- **No tryptophan** — balances the amino acid ratio from muscle meat, reducing excess serotonin production
|
||
|
||
**Practical:** 10-20g gelatin or collagen peptides daily, or regular bone broth as part of meals. GlyNAC (glycine + NAC together) has been shown to reverse aging biomarkers in human studies.
|
||
|
||
### 7.5 Aspirin — The Anti-Serotonin Rationale
|
||
|
||
Low-dose aspirin (75-100 mg/day with food) appears in the supplementation stack for reasons beyond its well-known anti-inflammatory (COX inhibition) effects:
|
||
- **Antiserotonergic** — aspirin reduces serotonin signalling. Given that chronically elevated serotonin is anti-metabolic, pro-fibrotic, promotes fat storage, and stimulates cortisol release (Section 17.2), this is a meaningful benefit.
|
||
- **Improves oxidative metabolism** — aspirin shifts cellular energy production toward more efficient oxidative phosphorylation
|
||
- **Anti-platelet** — reduces the pro-aggregatory effect of excess serotonin on platelets
|
||
|
||
**Caveats:** Aspirin carries GI and bleeding risks. This is an individual risk-benefit decision, ideally discussed with a physician. Not appropriate for everyone.
|
||
|
||
---
|
||
|
||
## 8. The Antioxidant Paradox
|
||
|
||
The goal of this framework is to support endogenous antioxidant systems, not to supplement with exogenous antioxidant scavengers. Understanding why is critical — it's one of the most replicated and most ignored findings in nutritional science.
|
||
|
||
### 8.1 Every Large RCT of Antioxidant Supplements Has Failed
|
||
|
||
| Trial | Intervention | Result |
|
||
|-------|-------------|--------|
|
||
| **ATBC (1994)** | Beta-carotene + vitamin E in smokers | Beta-carotene **increased** lung cancer by 18% and all-cause mortality by 8% |
|
||
| **CARET (1996)** | Beta-carotene + retinol | **Increased** lung cancer by 28%; trial stopped early for harm |
|
||
| **HOPE / HOPE-TOO** | Vitamin E (400 IU/day) | No cardiovascular benefit; possible increase in heart failure |
|
||
| **SELECT (2009)** | Vitamin E + selenium | No prostate cancer prevention; vitamin E group showed **increased** prostate cancer risk |
|
||
| **Cochrane meta-analysis (Bjelakovic, 2012)** | 78 RCTs, 296,707 participants | Beta-carotene, vitamin E, and high-dose vitamin A **increased** mortality |
|
||
|
||
This is not marginal — it is one of the most replicated harmful results in all of nutritional science.
|
||
|
||
### 8.2 Why Supplements Fail — ROS Are Signalling Molecules
|
||
|
||
The explanation is now well-understood through the hormesis framework:
|
||
|
||
**ROS are essential signals:**
|
||
- Mitochondrial ROS (superoxide, H₂O₂) activate adaptive stress responses: Nrf2 pathway, mitochondrial biogenesis, autophagy, DNA repair upregulation
|
||
- Exercise benefits *require* ROS signalling — ROS from muscle contraction trigger the beneficial adaptations
|
||
- **Ristow et al. (2009, PNAS):** Vitamin C + E supplementation **completely abolished** the insulin-sensitising effect of exercise by blocking the ROS signal
|
||
- Brief, pulsatile ROS → hormetic adaptation → stronger endogenous antioxidant defences (SOD, catalase, GPx, glutathione upregulation)
|
||
- Chronic, overwhelming ROS → damage (this is what aging produces)
|
||
- Antioxidant supplements suppress *both* the beneficial signalling AND the damaging excess — a net negative or wash
|
||
|
||
**"Antioxidant-rich foods" work via hormesis, not antioxidant activity:**
|
||
- Polyphenols (quercetin, EGCG, resveratrol, curcumin, sulforaphane) are actually **mild pro-oxidants** at cellular concentrations
|
||
- They trigger Nrf2 activation via the Keap1-Nrf2 pathway — generating a brief oxidative signal that upregulates the body's *endogenous* antioxidant and detoxification systems
|
||
- Sulforaphane is a perfect example: it's an electrophile that modifies Keap1, releasing Nrf2 to translocate to the nucleus and upregulate hundreds of protective genes
|
||
- The benefit comes from the *stress signal*, not from directly scavenging free radicals
|
||
- This is why whole foods work and isolated antioxidant supplements don't — the foods provide the right dose of hormetic stress in a complex matrix
|
||
|
||
### 8.3 Practical Implications
|
||
|
||
1. **Do not take antioxidant supplements** (vitamin E, vitamin C megadoses, beta-carotene) for "antioxidant" purposes.
|
||
2. **Do not take antioxidants around exercise or fasting.** They blunt the beneficial hormetic adaptive response. Avoid vitamin C, vitamin E, and NAC within several hours of training.
|
||
3. **Reframe "antioxidant-rich foods" as "hormetic stress foods."** Berries, cruciferous vegetables (cooked), green tea, turmeric, coffee — these work via hormesis, not scavenging.
|
||
4. **Support endogenous antioxidant production** instead: adequate selenium (GPx), zinc/copper/manganese (SOD), glycine + cysteine (glutathione synthesis). Provide the *substrates* for the body's own systems.
|
||
5. **Exercise, sauna, fasting, and cold exposure all work partly through hormesis.** Their benefits *depend on* the transient stress/ROS signal. Suppressing that signal with antioxidants is counterproductive.
|
||
|
||
---
|
||
|
||
## 9. Metabolic Assessment — Body Temperature and Self-Monitoring
|
||
|
||
Body temperature is the simplest and most informative self-measure of metabolic health. It directly reflects thyroid-driven metabolic rate, mitochondrial output, and CO2 production.
|
||
|
||
### 9.1 How to Measure
|
||
|
||
Use a simple oral thermometer. Two measurements daily:
|
||
|
||
| Metric | Optimal | Suboptimal | When to Measure |
|
||
|--------|---------|------------|-----------------|
|
||
| **Waking body temperature** | 36.6-37.0C (97.8-98.6F) | <36.4C (<97.5F) | Before getting out of bed |
|
||
| **Afternoon body temperature** | 37.0-37.2C (98.6-99.0F) | <36.8C (<98.2F) | Mid-afternoon (2-4pm) |
|
||
|
||
Track daily for at least 2 weeks to establish a baseline. If your temperature is rising over weeks and months, your metabolism is improving — this is a more meaningful signal than scale weight.
|
||
|
||
### 9.2 Other Self-Assessment Metrics
|
||
|
||
| Metric | Optimal | Suboptimal | Notes |
|
||
|--------|---------|------------|-------|
|
||
| **Resting heart rate** | 75-85 bpm | <60 bpm without athletic training | Very low RHR without fitness training may indicate metabolic suppression, not health |
|
||
| **Hands and feet** | Warm on waking | Cold extremities | Peripheral vasoconstriction = low thyroid/metabolic output |
|
||
| **Energy levels** | Steady throughout the day | Afternoon crashes, caffeine dependence | Metabolic flexibility = stable energy |
|
||
| **Sleep quality** | Fall asleep easily, wake refreshed | Difficulty sleeping, wake unrefreshed | Cortisol rhythm, melatonin production |
|
||
| **Digestion** | Regular, complete bowel movements | Constipation | Classic hypothyroid sign |
|
||
| **CO2 tolerance** (BOLT score) | >40 seconds comfortable breath hold after normal exhale | <20 seconds | Reflects metabolic CO2 production and chemoreceptor sensitivity |
|
||
|
||
### 9.3 Blood Tests Worth Requesting
|
||
|
||
If pursuing metabolic optimisation with a physician:
|
||
|
||
- **Free T3** (not just TSH) — the active thyroid hormone. Many hypothyroid patients have "normal" TSH but low free T3.
|
||
- **Reverse T3** (rT3) — the inactive form. High rT3 indicates the body is suppressing metabolism (stress, caloric restriction, illness).
|
||
- **T3/rT3 ratio** — more informative than either alone. Low ratio = metabolic suppression.
|
||
- **Fasting insulin** — early indicator of insulin resistance (earlier than fasting glucose).
|
||
- **DHEA-S** — barometer of adrenal/hormonal aging.
|
||
- **Pregnenolone** — the "mother hormone." Low pregnenolone = upstream bottleneck for all steroid hormones.
|
||
- **RBC magnesium** — more accurate than serum magnesium for assessing true magnesium status.
|
||
- **Fatty acid profile (RBC membrane)** — reveals the PUFA content of your cell membranes and tracks improvement as you eliminate seed oils.
|
||
- **25-OH Vitamin D** — target 40-60 ng/mL (100-150 nmol/L).
|
||
- **Homocysteine** — marker of methylation efficiency (B12, folate, B6 status).
|
||
|
||
---
|
||
|
||
## 10. CO2, Breathing, and Oxygen Delivery
|
||
|
||
CO2 is not merely a metabolic waste product — it is a vital physiological regulator. Understanding its role is central to the bioenergetic framework.
|
||
|
||
### 10.1 The Bohr Effect
|
||
|
||
CO2 is essential for oxygen delivery to tissues:
|
||
|
||
```
|
||
High CO2 environment (metabolically active tissue):
|
||
CO2 + H2O → H2CO3 → H+ + HCO3-
|
||
H+ binds hemoglobin → conformational change → releases O2
|
||
|
||
Low CO2 environment:
|
||
Hemoglobin holds O2 more tightly → LESS oxygen delivered to tissues
|
||
```
|
||
|
||
**Translation:** Without adequate CO2, hemoglobin cannot release oxygen efficiently. Even if blood oxygen saturation is 99%, tissues can be functionally hypoxic if CO2 is low. This creates a vicious cycle:
|
||
|
||
Low metabolism → less CO2 production → impaired O2 delivery → tissue hypoxia → HIF-1alpha stabilisation → shift to glycolysis → lactic acid → inflammation → further metabolic impairment → even lower metabolism
|
||
|
||
### 10.2 Other Roles of CO2
|
||
|
||
CO2 has direct physiological roles beyond oxygen delivery:
|
||
- **Vasodilation** — CO2 relaxes blood vessel smooth muscle, increasing blood flow. Low CO2 → vasoconstriction → reduced tissue perfusion.
|
||
- **Mast cell stabilisation** — CO2 reduces histamine release. Low CO2 → increased allergic/inflammatory responses.
|
||
- **Bronchodilation** — CO2 relaxes airway smooth muscle. Low CO2 → bronchoconstriction (relevant to asthma).
|
||
- **Anti-excitatory in the brain** — CO2 has a calming effect on neural excitability. Low CO2 → anxiety, increased seizure threshold.
|
||
- **pH buffering** — the bicarbonate buffer system (CO2/HCO3⁻) is the primary blood pH buffer.
|
||
|
||
### 10.3 The Respiratory Quotient Connection
|
||
|
||
Different fuels produce different amounts of CO2:
|
||
|
||
| Fuel | RQ (CO2 / O2) | CO2 Relative to Glucose |
|
||
|------|-------|-------------------------|
|
||
| Glucose | 1.0 | Maximum |
|
||
| Mixed diet | 0.8-0.85 | Moderate |
|
||
| Protein | ~0.8 | Moderate |
|
||
| Fat | ~0.7 | **30% less** |
|
||
|
||
A person burning primarily fat (keto, low-carb, chronic fasting) produces ~30% less CO2 than a person burning primarily glucose — leading to impaired oxygen delivery via the Bohr effect. This provides yet another mechanism by which chronic fat-burning is suboptimal.
|
||
|
||
### 10.4 Breathing Practices
|
||
|
||
- **Nasal breathing** (vs. mouth breathing) — especially during exercise. Nasal breathing retains CO2 more effectively, improving the Bohr effect and oxygen delivery. It also produces nitric oxide in the nasal passages (vasodilator, antimicrobial).
|
||
- **Chronic hyperventilation** (common with anxiety and chronic stress) blows off CO2 excessively, compounding tissue hypoxia. Many chronically stressed people are in a state of relative CO2 depletion.
|
||
- **CO2 tolerance training** — breathing exercises that build tolerance to CO2 (Buteyko method, extended exhale breathing, controlled breath holds) may improve tissue oxygenation. The BOLT score (body oxygen level test — comfortable breath hold time after a normal exhale) is a useful self-measure.
|
||
- **Body temperature and CO2** are directly linked — low body temperature indicates inadequate metabolic CO2 production and likely impaired oxygen delivery.
|
||
|
||
---
|
||
|
||
## 11. Sleep and Circadian Rhythm
|
||
|
||
Sleep is non-negotiable for longevity. During sleep: growth hormone pulses (tissue repair), autophagy activates (cellular cleanup), glymphatic clearance removes brain waste (amyloid-beta, tau), cortisol reaches its nadir, and DNA repair peaks.
|
||
|
||
### 11.1 The Basics
|
||
|
||
- **7-9 hours per night** — consistently. Weekend "catch-up" doesn't reverse weekday damage.
|
||
- **Dark room** — blackout curtains or eye mask. Even dim light during sleep suppresses melatonin and impairs sleep architecture.
|
||
- **Cool room** — 18-20C (65-68F). Core temperature drop is a sleep signal.
|
||
- **Consistent timing** — same bed and wake time, even on weekends. The circadian clock is set by consistency.
|
||
|
||
### 11.2 Circadian Entrainment
|
||
|
||
- **Morning sunlight within 30 minutes of waking** — 10-30 minutes, no sunglasses. This is the single most powerful circadian signal. It sets the suprachiasmatic nucleus (SCN) master clock, which determines when melatonin rises ~14-16 hours later.
|
||
- **Avoid bright light after sunset** — especially blue-enriched light from screens. Night mode / blue-blocking glasses help but are imperfect. The best approach is dimming lights and minimising screen use in the last 1-2 hours before bed.
|
||
- **Avoid eating within 2-3 hours of sleep** — late eating disrupts circadian-metabolic coupling and impairs sleep quality.
|
||
|
||
### 11.3 Melatonin Protection
|
||
|
||
Melatonin is both a circadian hormone (pineal) and a mitochondrial antioxidant (subcellular). Protecting melatonin production supports both sleep and mitochondrial health.
|
||
|
||
- **Reduce fluoride exposure** — fluoride calcifies the pineal gland, reducing melatonin synthetic capacity (see Section 1.1).
|
||
- **Morning sunlight** — entrains circadian rhythm so melatonin peaks at the right time.
|
||
- **Evening darkness** — allows melatonin to rise naturally.
|
||
- **Near-infrared light exposure** (sunlight, red light therapy) — stimulates melatonin synthesis directly in mitochondria, independent of the pineal gland (Zimmerman & Reiter research).
|
||
|
||
---
|
||
|
||
## 12. Sunlight and Light Exposure
|
||
|
||
Covered in detail in PLAN.md Section 15.5. The evidence is striking.
|
||
|
||
### 12.1 Sun Avoidance Is Dangerous
|
||
|
||
**Lindqvist et al. (2014, Journal of Internal Medicine):** 29,518 Swedish women followed for 20 years. Women who avoided sun exposure had **2x higher all-cause mortality** compared to those with the highest sun exposure. The mortality risk of sun avoidance was **comparable to smoking.** This persisted after multivariate adjustment.
|
||
|
||
### 12.2 What Sunlight Provides
|
||
|
||
- **Nitric oxide release from skin** — UVA releases NO from nitrate/nitrite stores in the skin, significantly lowering blood pressure (Weller lab, University of Southampton). This may explain why cardiovascular mortality tracks inversely with sun exposure.
|
||
- **Vitamin D synthesis** — UVB → 7-dehydrocholesterol → vitamin D3. Oral supplementation may not replicate the full benefits (different kinetics, misses NO and other effects).
|
||
- **Photobiomodulation of Complex IV** — near-infrared (NIR) wavelengths (810-850nm) are absorbed by cytochrome c oxidase, dissociating inhibitory NO and increasing ETC throughput → more ATP. Sunlight is the original and most potent source of this.
|
||
- **Mitochondrial melatonin synthesis** — NIR stimulates melatonin production directly in mitochondria (distinct from pineal melatonin). This melatonin acts as a local antioxidant protecting the ETC.
|
||
- **Circadian entrainment** — morning sunlight sets the SCN master clock.
|
||
- **Beta-endorphin release** — UV triggers beta-endorphin production in skin → mood, pain modulation, stress reduction.
|
||
- **BDNF upregulation** — sunlight increases brain-derived neurotrophic factor.
|
||
|
||
### 12.3 Practical Guidance
|
||
|
||
- **Don't avoid sunlight.** Regular, moderate exposure without burning is likely net beneficial.
|
||
- **Build a base tan gradually.** Melanin is the body's evolved UV protection — more effective and less toxic than sunscreen chemicals.
|
||
- **Morning sunlight is non-negotiable.** 10-30 minutes, no sunglasses, no sunscreen.
|
||
- **Avoid burning, not tanning.** Cover up before you go red. Intermittent burns are the melanoma risk factor, not cumulative moderate exposure. Outdoor workers get *less* melanoma than indoor workers in many studies.
|
||
- **If sunscreen is needed** for prolonged intense exposure, use mineral-based (zinc oxide, titanium dioxide). Avoid chemical sunscreens (oxybenzone, avobenzone) — FDA studies show they are systemically absorbed within hours and are endocrine disruptors (estrogenic, anti-androgenic).
|
||
|
||
---
|
||
|
||
## 13. Exercise for Longevity
|
||
|
||
Exercise is the single most potent intervention for mitochondrial biogenesis, insulin sensitivity, and maintenance of metabolic rate with age. No drug, supplement, or therapy comes close.
|
||
|
||
### 13.1 Priority Order
|
||
|
||
1. **Resistance training** (3-4x/week) — builds and maintains muscle (metabolically active tissue), increases insulin sensitivity, stimulates growth hormone, counteracts sarcopenia. This is more important than cardio for longevity. Muscle is metabolically active tissue — the more you have, the more energy you burn at rest.
|
||
2. **Daily walking** (30-60+ minutes) — low-stress, sustainable, improves insulin sensitivity, supports circadian rhythm (morning outdoor walking). Nasal breathing during walks retains CO2 (Bohr effect — Section 10). The foundation.
|
||
3. **HIIT** (1-2x/week) — the most potent stimulus for mitochondrial biogenesis (PGC-1alpha). Robinson et al. (2017, Mayo Clinic) showed HIIT reversed age-related mitochondrial decline in older adults — mitochondrial protein content in older subjects actually exceeded young sedentary controls. Keep it brief and intense.
|
||
4. **Avoid chronic cardio** — extended high-intensity cardio elevates cortisol chronically, can suppress thyroid function, and depletes adaptive reserves. Walking + weights + occasional HIIT is superior to daily long runs.
|
||
|
||
### 13.2 Key Principles
|
||
|
||
- **Don't combine cold exposure with resistance training** — cold immediately after lifting blunts the muscle adaptation signal (same principle as the antioxidant paradox in Section 8 — the inflammatory signalling from exercise IS the adaptation stimulus).
|
||
- **Don't take antioxidant supplements around exercise** — vitamin C, vitamin E, and NAC blunt the ROS-mediated adaptation signal (Ristow et al., 2009).
|
||
- **Recovery matters** — adaptation happens during rest, not during the session. Overtraining is counterproductive.
|
||
- **Consistency beats intensity** — a sustainable routine you maintain for decades outperforms any short-term extreme program.
|
||
|
||
---
|
||
|
||
## 14. Sauna and Heat Exposure
|
||
|
||
Sauna is one of the most potent and underutilised longevity interventions, with remarkably strong epidemiological data.
|
||
|
||
### 14.1 The Evidence
|
||
|
||
**Laukkanen et al. (2015, JAMA Internal Medicine):** 2,315 Finnish men followed for 20 years. Compared to once-weekly sauna use:
|
||
- 2-3x/week → 24% reduction in all-cause mortality
|
||
- 4-7x/week → **40% reduction in all-cause mortality**
|
||
- Cardiovascular mortality showed even larger reductions
|
||
- The effect was dose-dependent and persisted after adjustment for fitness, socioeconomic status, and other confounders
|
||
|
||
### 14.2 Mechanisms
|
||
|
||
- **Heat shock proteins (HSPs):** Heat stress activates HSF1 (heat shock factor 1), which upregulates HSP70, HSP90, and small HSPs. These act as molecular chaperones — they refold misfolded proteins and prevent protein aggregation. This directly addresses proteostasis, one of the hallmarks of aging (PLAN.md Pillar IV).
|
||
- **Cardiovascular conditioning:** Sauna produces a cardiovascular response similar to moderate exercise — increased heart rate, cardiac output, and skin blood flow. Repeated exposure improves vascular function and reduces blood pressure.
|
||
- **Growth hormone pulse:** A single sauna session can increase growth hormone 2-5x (varies with temperature and duration). This supports tissue repair and fat metabolism.
|
||
- **BDNF increase:** Heat stress increases brain-derived neurotrophic factor — neuroprotective and supports neuroplasticity.
|
||
- **Endorphin release:** The "sauna glow" is partly endorphin-mediated.
|
||
- **Immune function:** Mild hyperthermia enhances immune cell function (NK cells, T cells).
|
||
|
||
### 14.3 Protocol
|
||
|
||
- **Temperature:** 80-100C (176-212F) for traditional Finnish sauna
|
||
- **Duration:** 15-20 minutes per session, or multiple shorter rounds
|
||
- **Frequency:** 3-5x/week minimum; the dose-response curve in the Finnish data suggests more is better
|
||
- **Contrast therapy:** Sauna → cold plunge (1-5 min) → sauna provides both heat shock protein and cold shock protein responses. This may be optimal for maximising the hormetic benefit.
|
||
- **Hydration:** Replace fluids lost through sweating. Include electrolytes (sodium, potassium, magnesium).
|
||
- **Post-sauna rewarming:** The rewarming phase after cold exposure also triggers HSP production — the body's thermogenic response activates the same proteostasis pathways.
|
||
|
||
---
|
||
|
||
## 15. Cold Exposure — Hormesis, Not Chronic
|
||
|
||
Cold exposure appears across multiple longevity pillars (cold shock proteins, PGC-1alpha/brown fat activation, norepinephrine anti-inflammatory effects). The benefits are real, but the framing must be consistent with the pro-metabolic framework.
|
||
|
||
### 15.1 The Tension
|
||
|
||
Cold exposure is a stressor that activates the sympathetic nervous system, triggers cortisol release, and — if chronic or excessive — can suppress thyroid function (the body downregulates T3 to conserve heat). This seems to contradict the pro-metabolic framework, which advocates for high metabolic rate and low cortisol.
|
||
|
||
### 15.2 The Resolution — Brief and Intermittent
|
||
|
||
The resolution is hormesis — the same principle that governs exercise, sauna, and fasting:
|
||
|
||
- **Brief cold exposure** (1-5 minutes, cold plunge at 2-11C or cold shower) triggers a large norepinephrine spike (2-3x baseline) that is anti-inflammatory, mood-elevating, and activates brown adipose tissue
|
||
- **Cold shock proteins** (especially RBM3) are neuroprotective and are produced in response to brief cold
|
||
- **The rewarming phase** may be where much of the benefit lies — the body's rewarming response includes heat shock protein production (same proteostasis mechanism as sauna)
|
||
- **Chronic cold** (living in cold environments, prolonged ice baths) is a different stimulus — it can suppress thyroid function and reduce metabolic rate, which is counterproductive
|
||
|
||
This is exactly parallel to exercise: brief, intense stress is hormetically beneficial; chronic overexertion is harmful.
|
||
|
||
### 15.3 Protocol
|
||
|
||
1. **1-5 minute cold plunges or cold showers** — followed by natural rewarming (not immediately jumping into a hot shower).
|
||
2. **3-5x/week** — intermittent, not constant.
|
||
3. **Pair with sauna if possible** — contrast therapy (sauna → cold → sauna) provides both HSP and cold shock protein responses.
|
||
4. **Do NOT combine with resistance training** — cold immediately after lifting suppresses the inflammatory signalling required for muscle adaptation and hypertrophy. Separate by several hours.
|
||
5. **Monitor thyroid markers** if practicing regular cold exposure — free T3, reverse T3, body temperature. If T3 drops or body temperature declines, reduce frequency.
|
||
6. **The norepinephrine spike is the primary acute benefit** — anti-inflammatory (suppresses TNF-alpha, IL-6), attention-enhancing, mood-elevating. This doesn't require extreme cold or long duration.
|
||
|
||
---
|
||
|
||
## 16. Gut Health and the Microbiome
|
||
|
||
The gut microbiome influences inflammation, immune function, neurotransmitter production (including serotonin — see Section 17.2), nutrient absorption, and metabolic health. Gut dysbiosis increases with age and drives multiple hallmarks of aging. See PLAN.md Section 14 for the full research plan.
|
||
|
||
### 16.1 Key Interventions
|
||
|
||
**Fermented foods — the strongest evidence:**
|
||
The Stanford Sonnenburg lab study (2021) is the landmark result: a high-fermented-food diet for 10 weeks increased microbiome diversity and reduced inflammatory markers (including IL-6) more effectively than a high-fibre diet. This was surprising — diversity, not fibre, was the key.
|
||
|
||
- **Best sources:** Kimchi, sauerkraut, kefir, yogurt (full-fat, live cultures), kombucha, kvass
|
||
- **Fermented soy:** Miso, natto, tempeh — provide unique benefits (vitamin K2 from natto, spermidine) but contain phytoestrogens (partially degraded by fermentation). Use in moderation (Section 3.5).
|
||
|
||
**Prebiotic fibre diversity:**
|
||
- Onions, garlic, leeks, asparagus, Jerusalem artichoke, chicory root, dandelion greens, jicama
|
||
- These feed beneficial bacteria, especially butyrate-producers (Faecalibacterium, Roseburia)
|
||
- **30+ plant species per week** (American Gut Project finding) — microbiome diversity correlates strongly with plant food diversity. Variety matters more than volume.
|
||
|
||
**Resistant starch:**
|
||
- Cooked-and-cooled potatoes, cooked-and-cooled rice, green bananas, plantains
|
||
- Resists digestion and reaches the colon intact, where it feeds butyrate-producing bacteria
|
||
- Butyrate is the primary fuel for colonocytes and maintains gut barrier integrity (tight junction proteins)
|
||
|
||
**Bone broth / gelatin / collagen:**
|
||
- Glycine and glutamine support intestinal epithelial cell integrity and mucus production
|
||
- May help seal "leaky gut" by supporting tight junction proteins (claudins, occludin, ZO-1)
|
||
- Also provides amino acid balance (glycine without tryptophan — see Section 7.4 and Section 17.2)
|
||
|
||
### 16.2 What Damages the Gut
|
||
|
||
- **Seed oils** — PUFAs oxidise in the gut lining, driving inflammation and enterochromaffin cell activation (→ excess serotonin)
|
||
- **Unnecessary antibiotics** — devastate microbiome diversity. Some species may take months or years to recover. Each course of broad-spectrum antibiotics permanently alters the microbiome.
|
||
- **Chronic stress** — cortisol increases gut permeability ("leaky gut"), allowing bacterial endotoxins (LPS) into the bloodstream
|
||
- **NSAIDs** (chronic use, not occasional low-dose aspirin) — damage the intestinal epithelium
|
||
- **Alcohol** (excess) — directly damages gut barrier, alters microbiome composition
|
||
- **Emulsifiers and additives** in ultra-processed foods — polysorbate 80, carboxymethylcellulose, and carrageenan have been shown to degrade the mucus layer and increase intestinal permeability in animal studies
|
||
|
||
### 16.3 The Tryptophan/Kynurenine Connection
|
||
|
||
With aging and gut dysbiosis, tryptophan metabolism shifts:
|
||
- More tryptophan is diverted to the **kynurenine pathway**, producing inflammatory metabolites like quinolinic acid (neurotoxic, excitotoxic)
|
||
- More tryptophan is converted to **serotonin** by gut enterochromaffin cells — ~95% of total body serotonin is gut-derived. Gut inflammation increases serotonin production, which drives further inflammation, fibrosis, and cortisol release (see Section 17.2)
|
||
- Less tryptophan is available for beneficial pathways
|
||
|
||
Maintaining gut health (eliminating seed oils, supporting the microbiome, reducing inflammation) helps keep tryptophan metabolism in balance.
|
||
|
||
---
|
||
|
||
## 17. Stress and Hormonal Balance
|
||
|
||
Chronic stress (elevated cortisol) is profoundly anti-metabolic: it suppresses thyroid function (T4→rT3), promotes muscle catabolism, impairs sleep, raises blood glucose, promotes visceral fat storage, and suppresses immune function. Managing stress is not a soft lifestyle recommendation — it's a hard metabolic intervention.
|
||
|
||
### 17.1 Cortisol Management
|
||
|
||
- **Adequate caloric intake** — undereating is a stress signal that elevates cortisol. The body interprets caloric restriction as famine and responds with a cortisol-driven survival program (see Section 18.1).
|
||
- **Adequate carbohydrate** — low carbohydrate intake forces cortisol-driven gluconeogenesis. Providing dietary glucose prevents this entirely.
|
||
- **Adequate sleep** — sleep deprivation raises cortisol 37-45%.
|
||
- **Adequate salt** — low sodium elevates aldosterone and cortisol.
|
||
- **Morning sunlight** — sets the cortisol-melatonin rhythm (cortisol should peak in the morning and decline through the day).
|
||
- **Social connection** — isolation is a chronic stressor with measurable cortisol effects.
|
||
|
||
### 17.2 Serotonin — The Anti-Metabolic Excess
|
||
|
||
Serotonin is widely mischaracterised as a "happiness chemical." In fact, ~95% of serotonin is produced in the gut by enterochromaffin cells — it is released in response to gut irritation, inflammation, toxins, and stress. It is fundamentally a gut alarm signal. In the brain, serotonin's role is more accurately described as behavioural inhibition (suppressing action, risk-taking, dominance) rather than producing happiness. Dopamine is the reward/motivation signal. See METABOLISM_AND_AGING.md Section 8.5 for the full analysis.
|
||
|
||
**What chronically elevated serotonin does:**
|
||
- Suppresses mitochondrial respiration and thermogenesis → directly anti-metabolic
|
||
- Promotes fibrosis in multiple organs (liver, lung, heart) — serotonin is a potent fibroblast mitogen
|
||
- Causes vasoconstriction (migraines, pulmonary hypertension, Raynaud's)
|
||
- Promotes fat storage and insulin resistance in the liver
|
||
- Stimulates cortisol release from the adrenal glands (amplifying the cortisol burden)
|
||
- Promotes inflammation and oedema
|
||
- Suppresses dopamine signalling (anhedonia, low motivation)
|
||
|
||
**What drives chronic serotonin elevation:**
|
||
- Gut dysbiosis and intestinal inflammation (damaged gut → enterochromaffin cell activation)
|
||
- Chronic stress (stress → gut permeability → inflammation → serotonin)
|
||
- Seed oil-driven gut inflammation
|
||
- Excess unbalanced tryptophan intake (muscle meat without gelatin/bone broth)
|
||
- SSRIs (by design, these increase serotonin signalling)
|
||
|
||
**Natural serotonin modulation (reducing excess):**
|
||
- **Gelatin / bone broth / collagen** — provides glycine and proline without tryptophan, rebalancing amino acid intake (Section 7.4)
|
||
- **Aspirin** — antiserotonergic, reduces serotonin signalling (Section 7.5)
|
||
- **Reducing gut inflammation** — eliminate seed oils, proper food preparation (Section 3), support gut barrier integrity (Section 16)
|
||
- **Adequate sunlight** — healthy circadian rhythm converts daytime serotonin into melatonin at night
|
||
- **Adequate carbohydrate** — reduces cortisol, which otherwise drives tryptophan toward both serotonin and kynurenine pathways
|
||
- **Cyproheptadine** — pharmaceutical serotonin antagonist (also antihistamine); used in some pro-metabolic protocols. Physician-supervised.
|
||
|
||
**SSRIs — the concern:**
|
||
SSRIs increase serotonergic signalling by blocking reuptake. Their side-effect profile is entirely consistent with serotonin excess: weight gain, sexual dysfunction, emotional blunting, GI disturbance, increased bleeding risk, bone loss (increased fracture risk in elderly), and bruxism. Long-term use is associated with worsening metabolic markers. Withdrawal effects are severe and prolonged, suggesting deep neuroadaptation. This does not mean SSRIs are never appropriate, but it suggests that chronic serotonin elevation is not a path to health or longevity.
|
||
|
||
### 17.3 Estrogen Balance
|
||
|
||
Excess estrogenic signalling is pro-aging in both sexes — in males via aromatase conversion of testosterone, in females via estrogen dominance over declining progesterone. See METABOLISM_AND_AGING.md Section 8.2.
|
||
|
||
- **Minimise phytoestrogen exposure** — unfermented soy, flaxseed, beer/hops (Section 3.5).
|
||
- **Minimise xenoestrogen exposure** — chemical sunscreens, BPA/BPS, phthalates (Section 1.3).
|
||
- **Support liver detoxification of estrogen** — adequate B vitamins, cruciferous vegetables (cooked — the DIM/I3C pathway helps metabolise estrogen, but raw cruciferous suppress thyroid; Section 3.1).
|
||
- **Maintain healthy body fat percentage** — adipose tissue contains aromatase, converting testosterone to estradiol. More fat = more aromatase = more estrogen.
|
||
|
||
---
|
||
|
||
## 18. Conventional Wisdom Under Scrutiny
|
||
|
||
Several commonly recommended longevity strategies are internally contradictory with the bioenergetic framework. Understanding why helps avoid well-intentioned but counterproductive interventions.
|
||
|
||
### 18.1 Caloric Restriction — Overrated and Possibly Counterproductive
|
||
|
||
Caloric restriction is often described as "the most robust lifespan intervention across species." This requires major qualification.
|
||
|
||
**CR reduces metabolic rate — which we argue is pro-aging:**
|
||
- CR consistently reduces basal metabolic rate, body temperature, T3, sex hormones (testosterone, estradiol, progesterone), and immune function
|
||
- These are exactly the biomarkers this framework identifies as signs of *accelerated* aging
|
||
- CR-restricted animals are cold, infertile, immunocompromised, and low-energy — they live longer in sterile cages but would die quickly in the wild
|
||
- The body interprets CR as famine and responds with a survival program that sacrifices reproduction and immune defence for metabolic conservation — this is managed decline, not rejuvenation
|
||
|
||
**The lab animal confound:**
|
||
- Virtually all CR studies use standard lab chow high in omega-6 PUFAs (soybean oil is a common ingredient). Eating *less* of a PUFA-rich processed diet = less PUFA damage. The "CR effect" may largely be a "less seed oil" effect.
|
||
- Control animals are often ad libitum fed — overfed, sedentary, metabolically unhealthy. Extending lifespan relative to an obese sedentary control is a low bar.
|
||
- When lab animal diets are optimised (better fat composition, adequate micronutrients), the CR effect is significantly attenuated.
|
||
|
||
**Primate data is mixed:**
|
||
- **NIA study (2012):** CR did NOT extend lifespan in rhesus monkeys
|
||
- **Wisconsin study (2009, 2014):** CR DID extend lifespan — but the control diet was worse (higher sucrose, different fat composition), and controls were genuinely overfed
|
||
- The difference may be diet quality, not calories
|
||
|
||
**CALERIE trial (humans):** Showed slower epigenetic aging (DunedinPACE) but also reduced bone mineral density, muscle mass, sex hormones, and body temperature. Trading slower epigenetic aging for weaker bones, less muscle, and hormonal suppression may not be a good trade.
|
||
|
||
**Blue Zones populations don't practice CR.** They eat to satisfaction, often including significant carbohydrate. Okinawans practiced "hara hachi bu" (eat until 80% full) — mild moderation, not CR. They ate sweet potatoes, pork, and had active lifestyles.
|
||
|
||
**Better alternative:** Time-restricted eating or intermittent fasting (16:8, occasional 24h fasts) provides periodic mTOR downregulation and autophagy activation without chronic metabolic suppression. Eat adequately during eating windows; fast periodically for hormetic benefit.
|
||
|
||
### 18.2 Metformin — A Mitochondrial Poison
|
||
|
||
Metformin is the most commonly discussed "longevity drug." Its primary mechanism is **inhibition of Complex I** of the mitochondrial electron transport chain.
|
||
|
||
**The contradiction:** Pillar VII of the plan is entirely focused on enhancing ETC function — improving Complex I-IV activity, boosting mitochondrial biogenesis, restoring NAD+/NADH ratios. Metformin does the *opposite*. We cannot simultaneously advocate for mitochondrial optimisation and recommend a mitochondrial poison.
|
||
|
||
**Specific concerns:**
|
||
- **Blunts exercise adaptation:** Konopka et al. (2019) showed metformin attenuates mitochondrial biogenesis, cardiorespiratory fitness gains, and muscle hypertrophy in response to exercise. Since exercise is the most potent anti-aging intervention, a drug that blunts it is directly counterproductive.
|
||
- **Lactic acidosis:** By inhibiting Complex I, metformin shifts metabolism toward glycolysis → lactate production.
|
||
- **B12 depletion:** Long-term use causes vitamin B12 malabsorption — B12 is essential for DNA methylation and ETC function.
|
||
- **GI disruption:** Nausea, diarrhea, microbiome disruption — contradicting the gut health pillar.
|
||
|
||
**The TAME trial** may show benefit in humans, but even if it does, it may simply demonstrate that inhibiting Complex I in people eating a high-PUFA processed diet reduces the damage from that diet. It doesn't mean metformin is "anti-aging."
|
||
|
||
**Alternatives that don't poison the ETC:**
|
||
|
||
| Desired Effect | Metformin Route | Alternative |
|
||
|---------------|----------------|-------------|
|
||
| AMPK activation | Complex I poisoning | Exercise, fasting, berberine |
|
||
| Insulin sensitisation | Hepatic glucose output | Exercise, seed oil elimination, berberine |
|
||
| Anti-inflammatory | Indirect | Seed oil elimination, exercise, curcumin, cold exposure |
|
||
|
||
**Berberine** may be a reasonable alternative — it activates AMPK without directly inhibiting Complex I (its mechanism involves mitochondrial membrane effects but is less directly toxic to the ETC).
|
||
|
||
### 18.3 Ketogenic Diet — A Stress State, Not an Optimisation
|
||
|
||
Ketosis is the body's emergency backup fuel system, activated when liver glycogen is depleted and glucose is insufficient for brain needs.
|
||
|
||
**The problems with chronic keto:**
|
||
|
||
1. **Cortisol elevation:** The body still needs ~120g/day glucose for the brain, red blood cells, and other obligate glucose users. Without dietary glucose, it must produce it via cortisol-driven gluconeogenesis — breaking down muscle protein. Chronic keto = chronic cortisol.
|
||
|
||
2. **Thyroid suppression:** T4→T3 conversion requires adequate insulin, which requires adequate carbohydrate. Keto consistently shows reduced T3 → lower body temperature → lower metabolic rate → lower CO2 production → impaired oxygen delivery. This directly contradicts the pro-metabolic framework.
|
||
|
||
3. **Increased mitochondrial ROS:** Chronic fat oxidation forces a higher FADH2/NADH ratio → more reverse electron transport at Complex I → more superoxide (Section 5.1). If the fats being burned are stored PUFAs from prior seed oil consumption, the peroxidation risk is compounded.
|
||
|
||
4. **Reduced CO2 production:** Fat oxidation has an RQ of 0.7 vs 1.0 for glucose — 30% less CO2 per O2 consumed. Less CO2 → impaired Bohr effect → tissue hypoxia (Section 10).
|
||
|
||
**What keto's benefits may actually come from:**
|
||
- BHB (beta-hydroxybutyrate) signalling — BHB is an HDAC inhibitor and anti-inflammatory. But BHB is also produced during *fasting*. No need for chronic keto to access it.
|
||
- Reduced seizures (the original medical use) — a legitimate clinical application for epilepsy, but a therapeutic effect in a disease state doesn't mean it optimises healthy physiology.
|
||
|
||
**Better alternative:** Brief fasting (16-24h) provides BHB exposure and autophagy activation without chronic thyroid suppression and cortisol elevation. Occasional 24-48h fasts for deeper hormesis, not chronic carbohydrate deprivation.
|
||
|
||
### 18.4 Rapamycin — An Immunosuppressant
|
||
|
||
Rapamycin inhibits mTORC1, suppressing protein synthesis and activating autophagy. It is clinically used as an **immunosuppressant** for organ transplant rejection.
|
||
|
||
**The contradiction:** The plan advocates for immune system rejuvenation (thymic regeneration, NK cell enhancement, naive T cell restoration). Rapamycin suppresses T cell proliferation, B cell antibody production, and dendritic cell maturation. We cannot simultaneously advocate for immune rejuvenation and recommend an immunosuppressive drug.
|
||
|
||
**Additional concerns:**
|
||
- Impaired wound healing (mTOR is required for tissue repair)
|
||
- Muscle wasting — mTOR is essential for muscle protein synthesis; chronic inhibition → sarcopenia
|
||
- Insulin resistance via mTORC2 inhibition at chronic/high doses
|
||
- Metabolic rate suppression — mTOR inhibition reduces anabolic processes
|
||
|
||
**The Mannick et al. (2014) nuance:** Low-dose, intermittent rapamycin *improved* immune function (vaccine response) in elderly humans. But the dose was very specific (low-dose, 6 weeks only) — likely a transient hormetic effect, not sustained immune improvement. Chronic rapamycin remains immunosuppressive.
|
||
|
||
**Alternatives:**
|
||
|
||
| Desired Effect | Rapamycin Route | Alternative |
|
||
|---------------|----------------|-------------|
|
||
| Autophagy induction | mTOR inhibition | Fasting, spermidine, coffee, exercise, trehalose |
|
||
| mTOR downregulation | Direct inhibition | Periodic fasting, protein cycling |
|
||
| SASP suppression | Reduces SASP | Senolytics (clear the cells), fisetin, curcumin |
|
||
|
||
**Mouse lifespan context:** Lab mice are kept in sterile, pathogen-free environments where immunosuppression has minimal cost. Free-living humans face infections, need wound healing, and require robust immune surveillance for cancer and senescent cells. The mouse results may not translate.
|
||
|
||
---
|
||
|
||
*This document is a companion to METABOLISM_AND_AGING.md (the biochemical framework), PLAN.md (the comprehensive research plan), and the FAT_LOSS guides (focused application). For the full science behind any topic mentioned here, see those documents.*
|